|
US20120196370A1
(en)
|
2010-12-03 |
2012-08-02 |
Fyodor Urnov |
Methods and compositions for targeted genomic deletion
|
|
EP2206723A1
(en)
|
2009-01-12 |
2010-07-14 |
Bonas, Ulla |
Modular DNA-binding domains
|
|
US20110239315A1
(en)
*
|
2009-01-12 |
2011-09-29 |
Ulla Bonas |
Modular dna-binding domains and methods of use
|
|
WO2011002503A1
(en)
|
2009-06-30 |
2011-01-06 |
Sangamo Biosciences, Inc. |
Rapid screening of biologically active nucleases and isolation of nuclease-modified cells
|
|
EP3456826B1
(en)
*
|
2009-12-10 |
2023-06-28 |
Regents of the University of Minnesota |
Tal effector-mediated dna modification
|
|
US20110203012A1
(en)
*
|
2010-01-21 |
2011-08-18 |
Dotson Stanton B |
Methods and compositions for use of directed recombination in plant breeding
|
|
EP2534163B1
(en)
*
|
2010-02-09 |
2015-11-04 |
Sangamo BioSciences, Inc. |
Targeted genomic modification with partially single-stranded donor molecules
|
|
KR101880536B1
(ko)
*
|
2010-04-26 |
2018-07-23 |
상가모 테라퓨틱스, 인코포레이티드 |
아연 핑거 뉴클레아제를 사용하는 로사 좌위의 게놈 편집
|
|
JP6208580B2
(ja)
|
2010-05-17 |
2017-10-04 |
サンガモ セラピューティクス， インコーポレイテッド |
新規のｄｎａ結合タンパク質及びその使用
|
|
MY185668A
(en)
|
2010-06-02 |
2021-05-28 |
Evolva Inc |
Recombinant production of steviol glycosides
|
|
EP2392208B1
(en)
*
|
2010-06-07 |
2016-05-04 |
Helmholtz Zentrum München Deutsches Forschungszentrum für Gesundheit und Umwelt (GmbH) |
Fusion proteins comprising a DNA-binding domain of a Tal effector protein and a non-specific cleavage domain of a restriction nuclease and their use
|
|
EP2580331A4
(en)
*
|
2010-06-14 |
2013-11-27 |
Univ Iowa State Res Found Inc |
NUCLEASE ACTIVITY OF THE TAL EFFECTOR AND FUSION PROTEIN FOKI
|
|
CA2993567C
(en)
|
2010-07-21 |
2022-06-28 |
Sangamo Biosciences, Inc. |
Methods and compositions for modification of a t-cell receptor gene
|
|
CA2828239C
(en)
|
2011-02-25 |
2020-10-06 |
Recombinetics, Inc. |
Genetically modified animals and methods for making the same
|
|
US20240397918A1
(en)
*
|
2011-02-25 |
2024-12-05 |
Recombinetics, Inc. |
Non-meiotic allele introgression
|
|
US9528124B2
(en)
|
2013-08-27 |
2016-12-27 |
Recombinetics, Inc. |
Efficient non-meiotic allele introgression
|
|
US10920242B2
(en)
|
2011-02-25 |
2021-02-16 |
Recombinetics, Inc. |
Non-meiotic allele introgression
|
|
CA3111953C
(en)
*
|
2011-04-05 |
2023-10-24 |
Cellectis |
Method for the generation of compact tale-nucleases and uses thereof
|
|
WO2012149470A1
(en)
*
|
2011-04-27 |
2012-11-01 |
Amyris, Inc. |
Methods for genomic modification
|
|
CN103597082B
(zh)
|
2011-06-06 |
2017-09-15 |
拜尔作物科学公司 |
用于在预选位点修饰植物基因组的方法和手段
|
|
AU2012284365B2
(en)
*
|
2011-07-15 |
2017-04-20 |
The General Hospital Corporation |
Methods of transcription activator like effector assembly
|
|
EP2734621B1
(en)
|
2011-07-22 |
2019-09-04 |
President and Fellows of Harvard College |
Evaluation and improvement of nuclease cleavage specificity
|
|
WO2013016446A2
(en)
|
2011-07-25 |
2013-01-31 |
Sangamo Biosciences, Inc. |
Methods and compositions for alteration of a cystic fibrosis transmembrane conductance regulator (cftr) gene
|
|
WO2013016434A1
(en)
*
|
2011-07-27 |
2013-01-31 |
The Board Institute, Inc. |
Compositions and methods of treating head and neck cancer
|
|
WO2013019745A1
(en)
*
|
2011-07-29 |
2013-02-07 |
Georgia Health Sciences University |
Methods and compositions for genetically modifiying cells
|
|
US20140309145A1
(en)
*
|
2011-07-29 |
2014-10-16 |
Cellectis Sa |
High throughput method for assembly and cloning polynucleotides comprising highly similar polynucleotidic modules
|
|
CN102787125B
(zh)
*
|
2011-08-05 |
2013-12-04 |
北京大学 |
一种构建tale重复序列的方法
|
|
KR102114493B1
(ko)
|
2011-08-08 |
2020-05-26 |
에볼바 에스아 |
스테비올 글리코시드의 재조합 생산
|
|
CN107287234A
(zh)
|
2011-08-22 |
2017-10-24 |
拜尔作物科学公司 |
修饰植物基因组的方法和手段
|
|
CA2848417C
(en)
|
2011-09-21 |
2023-05-02 |
Sangamo Biosciences, Inc. |
Methods and compositions for regulation of transgene expression
|
|
WO2013050611A1
(en)
|
2011-10-07 |
2013-04-11 |
Basf Plant Science Company Gmbh |
Method of producing plants having increased resistance to pathogens
|
|
WO2013050318A1
(en)
|
2011-10-07 |
2013-04-11 |
Basf Plant Science Company Gmbh |
Method of producing plants having increased resistance to pathogens
|
|
WO2013050593A1
(en)
|
2011-10-07 |
2013-04-11 |
Basf Plant Science Company Gmbh |
Method of producing plants having increased resistance to pathogens
|
|
WO2013053686A1
(en)
|
2011-10-10 |
2013-04-18 |
Basf Plant Science Company Gmbh |
Method of producing plants having increased resistance to pathogens
|
|
WO2013053711A1
(en)
|
2011-10-10 |
2013-04-18 |
Basf Plant Science Company Gmbh |
Method of producing plants having increased resistance to pathogens
|
|
US20140251317A1
(en)
|
2011-10-12 |
2014-09-11 |
Bayer Cropscience Ag |
Plants with decreased activity of a starch dephosphorylating enzyme
|
|
US20140283819A1
(en)
|
2011-10-12 |
2014-09-25 |
Bayer Cropscience Ag |
Plants with decreased activity of a starch dephosphorylating enzyme
|
|
EP3611261A1
(en)
|
2011-10-21 |
2020-02-19 |
Kyushu University, National University Corporation |
Method for designing rna binding protein uitilizing ppr motif, and use thereof
|
|
CA2852955C
(en)
|
2011-10-27 |
2021-02-16 |
Sangamo Biosciences, Inc. |
Methods and compositions for modification of the hprt locus
|
|
BR112014010537A2
(pt)
|
2011-10-31 |
2017-05-02 |
Pioneer Hi Bred Int |
método para modular a sensibilidade ao etileno, planta transgênica, proteína isolada, sequência de polinucleotídeos isolada, polipeptídeo com atividade regulatória de etileno, método para aumentar o rendimento em uma planta, método para melhorar um parâmetro agronômico de uma planta, método de seleção assistida por marcador de uma planta
|
|
JP6144691B2
(ja)
*
|
2011-11-16 |
2017-06-07 |
サンガモ セラピューティクス， インコーポレイテッド |
修飾されたｄｎａ結合タンパク質およびその使用
|
|
US10801017B2
(en)
*
|
2011-11-30 |
2020-10-13 |
The Broad Institute, Inc. |
Nucleotide-specific recognition sequences for designer TAL effectors
|
|
US20130137173A1
(en)
*
|
2011-11-30 |
2013-05-30 |
Feng Zhang |
Nucleotide-specific recognition sequences for designer tal effectors
|
|
US8450107B1
(en)
|
2011-11-30 |
2013-05-28 |
The Broad Institute Inc. |
Nucleotide-specific recognition sequences for designer TAL effectors
|
|
RU2624139C2
(ru)
|
2011-12-05 |
2017-06-30 |
Фэктор Байосайенс Инк. |
Способы и препараты для трансфекции клеток
|
|
US8497124B2
(en)
|
2011-12-05 |
2013-07-30 |
Factor Bioscience Inc. |
Methods and products for reprogramming cells to a less differentiated state
|
|
IN2014MN00974A
(enExample)
|
2011-12-16 |
2015-04-24 |
Targetgene Biotechnologies Ltd |
|
|
DE102011122267A1
(de)
|
2011-12-23 |
2013-06-27 |
Kws Saat Ag |
Neue aus Pflanzen stammende cis-regulatorische Elemente für die Entwicklung Pathogen-responsiver chimärer Promotoren
|
|
US9688997B2
(en)
|
2011-12-29 |
2017-06-27 |
Iowa State University Research Foundation, Inc. |
Genetically modified plants with resistance to Xanthomonas and other bacterial plant pathogens
|
|
GB201122458D0
(en)
|
2011-12-30 |
2012-02-08 |
Univ Wageningen |
Modified cascade ribonucleoproteins and uses thereof
|
|
EP2612918A1
(en)
|
2012-01-06 |
2013-07-10 |
BASF Plant Science Company GmbH |
In planta recombination
|
|
EA201400995A1
(ru)
|
2012-03-13 |
2015-02-27 |
Юниверсити Оф Гуэлф |
Способы повышения выносливости к тепловому стрессу и содержания аминокислот в растениях
|
|
WO2013136274A1
(en)
|
2012-03-13 |
2013-09-19 |
University Of Guelph |
Myb55 promoter and use thereof
|
|
EP3141259B1
(en)
*
|
2012-03-15 |
2019-07-31 |
Cellectis |
Repeat variable diresidues for targeting nucleotides
|
|
DK2828384T3
(en)
|
2012-03-23 |
2018-07-16 |
Cellectis |
PROCEDURE FOR SURVIVING SENSITIVITY TO CHEMICAL DNA MODIFICATIONS OF CONSTRUCTED SPEECH DNA BINDING DOMAINS
|
|
CN102628037B
(zh)
*
|
2012-03-31 |
2013-07-24 |
西南大学 |
家蚕油蚕基因BmBlos2遗传改造系统及其制备方法和应用
|
|
WO2013152220A2
(en)
*
|
2012-04-04 |
2013-10-10 |
Life Technologies Corporation |
Tal-effector assembly platform, customized services, kits and assays
|
|
ES2828663T3
(es)
|
2012-04-18 |
2021-05-27 |
Univ Leland Stanford Junior |
Dirección genética no disruptiva
|
|
US11518997B2
(en)
|
2012-04-23 |
2022-12-06 |
BASF Agricultural Solutions Seed US LLC |
Targeted genome engineering in plants
|
|
CN104364380B
(zh)
|
2012-04-25 |
2018-10-09 |
瑞泽恩制药公司 |
核酸酶介导的使用大靶向载体的靶向
|
|
EP3597741A1
(en)
|
2012-04-27 |
2020-01-22 |
Duke University |
Genetic correction of mutated genes
|
|
KR102091298B1
(ko)
|
2012-05-02 |
2020-03-19 |
다우 아그로사이언시즈 엘엘씨 |
말산 탈수소효소의 표적화된 변형
|
|
CA2871524C
(en)
*
|
2012-05-07 |
2021-07-27 |
Sangamo Biosciences, Inc. |
Methods and compositions for nuclease-mediated targeted integration of transgenes
|
|
WO2013169398A2
(en)
|
2012-05-09 |
2013-11-14 |
Georgia Tech Research Corporation |
Systems and methods for improving nuclease specificity and activity
|
|
SG10201806573TA
(en)
*
|
2012-05-25 |
2018-09-27 |
Cellectis |
Methods for engineering allogeneic and immunosuppressive resistant t cell for immunotherapy
|
|
US9605274B2
(en)
|
2012-05-25 |
2017-03-28 |
Evolutionary Genomics, Inc. |
Dirigent gene EG261 and its orthologs and paralogs and their uses for pathogen resistance in plants
|
|
CA2872128C
(en)
|
2012-05-25 |
2017-09-19 |
Evolutionary Genomics, Inc. |
Dirigent gene eg261 and its orthologs and paralogs and their uses for pathogen resistance in plants
|
|
PL4289948T3
(pl)
|
2012-05-25 |
2025-06-02 |
The Regents Of The University Of California |
Sposoby i kompozycje do modyfikacji kierowanego na rna docelowego dna i do nakierowanej na rna modulacji transkrypcji
|
|
US9890364B2
(en)
|
2012-05-29 |
2018-02-13 |
The General Hospital Corporation |
TAL-Tet1 fusion proteins and methods of use thereof
|
|
WO2013182910A2
(en)
*
|
2012-06-05 |
2013-12-12 |
Cellectis |
New transcription activator-like effector (tale) fusion protein
|
|
US9815877B2
(en)
|
2012-06-07 |
2017-11-14 |
The Children's Hospital Of Philadelphia |
Controlled gene expression methods
|
|
RU2014153918A
(ru)
|
2012-06-12 |
2016-07-27 |
Дженентек, Инк. |
Способы и композиции для получения условно нокаутных аллелей
|
|
WO2013188291A2
(en)
|
2012-06-15 |
2013-12-19 |
E. I. Du Pont De Nemours And Company |
Methods and compositions involving als variants with native substrate preference
|
|
EP2861737B1
(en)
|
2012-06-19 |
2019-04-17 |
Regents Of The University Of Minnesota |
Gene targeting in plants using dna viruses
|
|
AR091482A1
(es)
*
|
2012-06-21 |
2015-02-04 |
Recombinetics Inc |
Celulas modificadas geneticamente y metodos par su obtencion
|
|
US20150291951A1
(en)
*
|
2012-06-22 |
2015-10-15 |
Mayo Foundation For Medical Education And Research |
Genome editing
|
|
US20160281103A1
(en)
|
2012-07-06 |
2016-09-29 |
National Institute Of Agrobiological Sciences |
Wheat with increased number of grains and method for producing the same, and agent for increasing the number of wheat grains
|
|
US20150104873A1
(en)
*
|
2012-07-11 |
2015-04-16 |
University of Nevada, Las Vegas |
Genome Surgery with Paired, Permeant Endonuclease Construct
|
|
EP2872154B1
(en)
|
2012-07-11 |
2017-05-31 |
Sangamo BioSciences, Inc. |
Methods and compositions for delivery of biologics
|
|
HUE051612T2
(hu)
|
2012-07-11 |
2021-03-01 |
Sangamo Therapeutics Inc |
Eljárások és készítmények lizoszomális tárolási betegségek kezelésére
|
|
EP2687605A1
(en)
|
2012-07-19 |
2014-01-22 |
Biogemma |
Method for performing homologous recombination
|
|
WO2014018601A2
(en)
|
2012-07-24 |
2014-01-30 |
Cellectis |
New modular base-specific nucleic acid binding domains from burkholderia rhizoxinica proteins
|
|
KR20230065381A
(ko)
*
|
2012-07-25 |
2023-05-11 |
더 브로드 인스티튜트, 인코퍼레이티드 |
유도 ｄｎａ 결합 단백질 및 게놈 교란 도구 및 이의 적용
|
|
US10058078B2
(en)
|
2012-07-31 |
2018-08-28 |
Recombinetics, Inc. |
Production of FMDV-resistant livestock by allele substitution
|
|
PL2890780T3
(pl)
|
2012-08-29 |
2021-02-08 |
Sangamo Therapeutics, Inc. |
Sposoby i kompozycje do leczenia zaburzeń genetycznych
|
|
WO2014033556A2
(en)
*
|
2012-09-03 |
2014-03-06 |
Cellectis |
Methods for modulating tal specificity
|
|
WO2014039585A2
(en)
*
|
2012-09-04 |
2014-03-13 |
The Scripps Research Institute |
Chimeric polypeptides having targeted binding specificity
|
|
UA118090C2
(uk)
|
2012-09-07 |
2018-11-26 |
ДАУ АГРОСАЙЄНСІЗ ЕлЕлСі |
Спосіб інтегрування послідовності нуклеїнової кислоти, що представляє інтерес, у ген fad2 у клітині сої та специфічний для локусу fad2 білок, що зв'язується, здатний індукувати спрямований розрив
|
|
UA119135C2
(uk)
|
2012-09-07 |
2019-05-10 |
ДАУ АГРОСАЙЄНСІЗ ЕлЕлСі |
Спосіб отримання трансгенної рослини
|
|
BR112015004995B1
(pt)
|
2012-09-07 |
2023-05-02 |
Sangamo Biosciences, Inc. |
Método para modificação do genoma de uma célula, uso de uma célula, semente ou planta obtida pelo referido método e nuclease de dedo de zinco sítio específica
|
|
EP3257952B1
(en)
|
2012-09-11 |
2020-02-12 |
Life Technologies Corporation |
Nucleic acid amplification
|
|
WO2014043143A1
(en)
|
2012-09-11 |
2014-03-20 |
Life Technologies Corporation |
Nucleic acid amplification
|
|
WO2014059255A1
(en)
|
2012-10-12 |
2014-04-17 |
The General Hospital Corporation |
Transcription activator-like effector (tale) - lysine-specific demethylase 1 (lsd1) fusion proteins
|
|
WO2014070887A1
(en)
*
|
2012-10-30 |
2014-05-08 |
Recombinetics, Inc. |
Control of sexual maturation in animals
|
|
BR112015009812A2
(pt)
|
2012-10-31 |
2017-08-22 |
Cellectis |
Método para a inserção genética específica em um genoma de planta, célula de planta transformada e seu uso, planta resistente a herbicidas, kit, vetor, e célula hospedeira
|
|
CN104968193B
(zh)
|
2012-11-01 |
2021-02-09 |
塞尔克蒂斯股份有限公司 |
用于生成治疗性蛋白质的植物
|
|
MX363017B
(es)
|
2012-11-01 |
2019-03-04 |
Factor Bioscience Inc |
Métodos y productos para la expresión de proteínas en células.
|
|
JP2015534834A
(ja)
*
|
2012-11-20 |
2015-12-07 |
ジェイ．アール．シンプロット カンパニー |
Ｔａｌにより媒介されるトランファーｄｎａ挿入
|
|
CA2892448A1
(en)
|
2012-12-05 |
2014-06-12 |
Sangamo Biosciences, Inc. |
Methods and compositions for regulation of metabolic disorders
|
|
CN105142669B
(zh)
|
2012-12-06 |
2018-07-03 |
西格马-奥尔德里奇有限责任公司 |
基于crispr的基因组修饰和调控
|
|
WO2014093622A2
(en)
|
2012-12-12 |
2014-06-19 |
The Broad Institute, Inc. |
Delivery, engineering and optimization of systems, methods and compositions for sequence manipulation and therapeutic applications
|
|
WO2014093701A1
(en)
|
2012-12-12 |
2014-06-19 |
The Broad Institute, Inc. |
Functional genomics using crispr-cas systems, compositions, methods, knock out libraries and applications thereof
|
|
CN103013954B
(zh)
*
|
2012-12-17 |
2014-03-05 |
中国科学院遗传与发育生物学研究所 |
水稻基因badh2的定点敲除系统及其应用
|
|
US9708589B2
(en)
|
2012-12-18 |
2017-07-18 |
Monsanto Technology Llc |
Compositions and methods for custom site-specific DNA recombinases
|
|
US20140178561A1
(en)
*
|
2012-12-21 |
2014-06-26 |
Cellectis |
Potatoes with reduced cold-induced sweetening
|
|
AU2013361220A1
(en)
|
2012-12-21 |
2015-04-02 |
Pioneer Hi-Bred International, Inc. |
Compositions and methods for auxin-analog conjugation
|
|
CN105051195B
(zh)
|
2013-02-06 |
2019-09-06 |
埃沃尔瓦公司 |
用于提高莱鲍迪苷d和莱鲍迪苷m之产生的方法
|
|
AU2014214719B2
(en)
*
|
2013-02-07 |
2020-02-13 |
The General Hospital Corporation |
Tale transcriptional activators
|
|
CN105189771B
(zh)
|
2013-02-11 |
2019-11-05 |
埃沃尔瓦公司 |
在重组宿主中有效产生甜菊醇糖苷
|
|
CN103319574A
(zh)
*
|
2013-02-16 |
2013-09-25 |
清华大学 |
分离的多肽及其应用
|
|
AU2014218931C1
(en)
|
2013-02-20 |
2020-05-14 |
Regeneron Pharmaceuticals, Inc. |
Genetic modification of rats
|
|
WO2014128659A1
(en)
|
2013-02-21 |
2014-08-28 |
Cellectis |
Method to counter-select cells or organisms by linking loci to nuclease components
|
|
JP6491113B2
(ja)
|
2013-02-25 |
2019-03-27 |
サンガモ セラピューティクス， インコーポレイテッド |
ヌクレアーゼ媒介性遺伝子破壊を増強するための方法および組成物
|
|
ES2750550T3
(es)
*
|
2013-03-01 |
2020-03-26 |
Univ Minnesota |
Corrección de gen a base de TALEN
|
|
BR112015022742A2
(pt)
|
2013-03-11 |
2018-11-27 |
Pionner Hi Bred Int Inc |
métodos e composições que empregam um domínio de estabilização dependente de sulfonilureia
|
|
BR112015023286A2
(pt)
|
2013-03-14 |
2018-03-06 |
Arzeda Corp |
polipeptídeo recombinante com atividade da dicamba descarboxilase, construto de polinucleotídeo, célula, método de produção de uma célula hospedeira compreendendo um polinucleotídeo heterólogo que codifica um polipeptídeo tendo atividade da dicamba descarboxilase, método para descarboxilar dicamba, um derivado de dicamba ou um metabolito de dicamba, método para a detecção de um polipeptideo e método para a detecção da presença de um polinucleotideo que codifica um polipeptideo tendo atividade da dicamba descarboxilase
|
|
US20160053277A1
(en)
|
2013-03-14 |
2016-02-25 |
Pioneer Hi-Bred International, Inc. |
Compositions Having Dicamba Decarboxylase Activity and Methods of Use
|
|
KR20170108172A
(ko)
|
2013-03-14 |
2017-09-26 |
카리부 바이오사이언시스 인코포레이티드 |
핵산-표적화 핵산의 조성물 및 방법
|
|
US11039586B2
(en)
|
2013-03-15 |
2021-06-22 |
Monsanto Technology Llc |
Creation and transmission of megaloci
|
|
JP6591898B2
(ja)
*
|
2013-03-15 |
2019-10-16 |
セレクティス |
Ｆａｄ２−１ａ／１ｂ遺伝子の標的化ノックアウトを介した、大豆油組成物の改変
|
|
US20140363561A1
(en)
*
|
2013-03-15 |
2014-12-11 |
J.R. Simplot Company |
Tal-mediated transfer dna insertion
|
|
EP2970997A1
(en)
*
|
2013-03-15 |
2016-01-20 |
Regents of the University of Minnesota |
Engineering plant genomes using crispr/cas systems
|
|
US10793867B2
(en)
|
2013-03-15 |
2020-10-06 |
Monsanto Technology, Llc |
Methods for targeted transgene-integration using custom site-specific DNA recombinases
|
|
US10113162B2
(en)
|
2013-03-15 |
2018-10-30 |
Cellectis |
Modifying soybean oil composition through targeted knockout of the FAD2-1A/1B genes
|
|
US9828582B2
(en)
|
2013-03-19 |
2017-11-28 |
Duke University |
Compositions and methods for the induction and tuning of gene expression
|
|
WO2014161821A1
(en)
|
2013-04-02 |
2014-10-09 |
Bayer Cropscience Nv |
Targeted genome engineering in eukaryotes
|
|
US10501748B2
(en)
|
2013-04-05 |
2019-12-10 |
Dow Agrosciences Llc |
Methods and compositions for integration of an exogenous sequence within the genome of plants
|
|
HK1214302A1
(zh)
*
|
2013-04-16 |
2016-07-22 |
深圳华大基因科技服务有限公司 |
分离的寡核苷酸及其用途
|
|
CA2908697C
(en)
|
2013-04-16 |
2023-12-12 |
Regeneron Pharmaceuticals, Inc. |
Targeted modification of rat genome
|
|
ES2989650T3
(es)
|
2013-04-22 |
2024-11-27 |
Univ Kyushu Nat Univ Corp |
Proteína de unión a ADN que usa motivo de PPR, y uso de la misma
|
|
EP2796558A1
(en)
|
2013-04-23 |
2014-10-29 |
Rheinische Friedrich-Wilhelms-Universität Bonn |
Improved gene targeting and nucleic acid carrier molecule, in particular for use in plants
|
|
CN103233004B
(zh)
*
|
2013-04-28 |
2015-04-29 |
新疆农垦科学院 |
一种人工dna分子及检测目标基因表达的方法
|
|
WO2014186435A2
(en)
|
2013-05-14 |
2014-11-20 |
University Of Georgia Research Foundation, Inc. |
Compositions and methods for reducing neointima formation
|
|
AU2014279694B2
(en)
|
2013-06-14 |
2020-07-23 |
Cellectis |
Methods for non-transgenic genome editing in plants
|
|
EP3011033B1
(en)
|
2013-06-17 |
2020-02-19 |
The Broad Institute, Inc. |
Functional genomics using crispr-cas systems, compositions methods, screens and applications thereof
|
|
KR20240172759A
(ko)
|
2013-06-17 |
2024-12-10 |
더 브로드 인스티튜트, 인코퍼레이티드 |
간의 표적화 및 치료를 위한 ＣＲＩＳＰＲＣａｓ 시스템, 벡터 및 조성물의 전달 및 용도
|
|
CA2915837A1
(en)
*
|
2013-06-17 |
2014-12-24 |
The Broad Institute, Inc. |
Optimized crispr-cas double nickase systems, methods and compositions for sequence manipulation
|
|
EP2818867A1
(en)
|
2013-06-27 |
2014-12-31 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Antibodies conjugated to at least one nucleic acid molecule and their use in multiplex immuno-detection assays
|
|
WO2015002780A1
(en)
*
|
2013-07-01 |
2015-01-08 |
The Board Of Regents Of The University Of Texas System |
Transcription activator-like effector (tale) libraries and methods of synthesis and use
|
|
US11306328B2
(en)
|
2013-07-26 |
2022-04-19 |
President And Fellows Of Harvard College |
Genome engineering
|
|
WO2015017866A1
(en)
*
|
2013-08-02 |
2015-02-05 |
Enevolv, Inc. |
Processes and host cells for genome, pathway, and biomolecular engineering
|
|
JP5931022B2
(ja)
|
2013-08-09 |
2016-06-08 |
国立大学法人広島大学 |
Ｄｎａ結合ドメインを含むポリペプチド
|
|
US10006011B2
(en)
|
2013-08-09 |
2018-06-26 |
Hiroshima University |
Polypeptide containing DNA-binding domain
|
|
US9163284B2
(en)
|
2013-08-09 |
2015-10-20 |
President And Fellows Of Harvard College |
Methods for identifying a target site of a Cas9 nuclease
|
|
CA2923223C
(en)
|
2013-09-04 |
2021-11-16 |
Kws Saat Se |
Helminthosporium turcicum-resistant plant
|
|
DE102013014637A1
(de)
|
2013-09-04 |
2015-03-05 |
Kws Saat Ag |
HELMlNTHOSPORlUM TURClCUM-RESlSTENTE PFLANZE
|
|
US9340800B2
(en)
|
2013-09-06 |
2016-05-17 |
President And Fellows Of Harvard College |
Extended DNA-sensing GRNAS
|
|
US9322037B2
(en)
|
2013-09-06 |
2016-04-26 |
President And Fellows Of Harvard College |
Cas9-FokI fusion proteins and uses thereof
|
|
IL312865B2
(en)
|
2013-09-11 |
2025-06-01 |
Eagle Biologics Inc |
Liquid protein formulations containing viscosity-lowering agents
|
|
CN105579068A
(zh)
*
|
2013-09-23 |
2016-05-11 |
伦斯勒理工学院 |
在各种细胞群中纳米颗粒介导的基因传递、基因组编辑和靶向配体的修饰
|
|
CA2927180A1
(en)
|
2013-10-18 |
2015-04-23 |
Pioneer Hi-Bred International, Inc. |
Glyphosate-n-acetyltransferase (glyat) sequences and methods of use
|
|
US10779518B2
(en)
|
2013-10-25 |
2020-09-22 |
Livestock Improvement Corporation Limited |
Genetic markers and uses therefor
|
|
EP3062819B1
(en)
|
2013-11-03 |
2021-12-22 |
The Regents of The University of California |
Ionic liquids for transdermal drug delivery
|
|
EP3066202B1
(en)
|
2013-11-04 |
2021-03-03 |
Dow AgroSciences LLC |
Optimal soybean loci
|
|
EP3066110B1
(en)
|
2013-11-04 |
2021-12-29 |
Corteva Agriscience LLC |
Optimal maize loci
|
|
WO2015066634A2
(en)
|
2013-11-04 |
2015-05-07 |
Dow Agrosciences Llc |
Optimal soybean loci
|
|
KR102269769B1
(ko)
|
2013-11-04 |
2021-06-28 |
코르테바 애그리사이언스 엘엘씨 |
최적 메이즈 유전자좌
|
|
CN105683375B
(zh)
|
2013-11-06 |
2021-02-02 |
国立大学法人广岛大学 |
用于插入核酸的载体
|
|
WO2015070062A1
(en)
*
|
2013-11-07 |
2015-05-14 |
Massachusetts Institute Of Technology |
Cell-based genomic recorded accumulative memory
|
|
EP2878667A1
(en)
|
2013-11-29 |
2015-06-03 |
Institut Pasteur |
TAL effector means useful for partial or full deletion of DNA tandem repeats
|
|
CN103710360A
(zh)
*
|
2013-12-03 |
2014-04-09 |
南方医科大学珠江医院 |
提高HepGL肝癌细胞氨基甲酰磷酸合成酶表达的方法
|
|
HUE041331T2
(hu)
|
2013-12-11 |
2019-05-28 |
Regeneron Pharma |
Módszerek és készítmények a genom célzott módosításához
|
|
SG10201700961TA
(en)
|
2013-12-11 |
2017-04-27 |
Regeneron Pharma |
Methods and compositions for the targeted modification of a genome
|
|
EP3080271B1
(en)
|
2013-12-12 |
2020-02-12 |
The Broad Institute, Inc. |
Systems, methods and compositions for sequence manipulation with optimized functional crispr-cas systems
|
|
EP3080259B1
(en)
|
2013-12-12 |
2023-02-01 |
The Broad Institute, Inc. |
Engineering of systems, methods and optimized guide compositions with new architectures for sequence manipulation
|
|
WO2015089354A1
(en)
|
2013-12-12 |
2015-06-18 |
The Broad Institute Inc. |
Compositions and methods of use of crispr-cas systems in nucleotide repeat disorders
|
|
EP3653229A1
(en)
|
2013-12-12 |
2020-05-20 |
The Broad Institute, Inc. |
Delivery, use and therapeutic applications of the crispr-cas systems and compositions for genome editing
|
|
CN105899658B
(zh)
|
2013-12-12 |
2020-02-18 |
布罗德研究所有限公司 |
针对hbv和病毒性疾病以及障碍的crispr-cas系统和组合物的递送、用途和治疗应用
|
|
JP2017505756A
(ja)
|
2013-12-13 |
2017-02-23 |
ザ ジェネラル ホスピタル コーポレイション |
可溶性高分子量（ｈｍｗ）タウ種およびその用途
|
|
WO2015092460A1
(en)
|
2013-12-18 |
2015-06-25 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
New gene mutations for the diagnosis of arthrogryposis multiplex congenita and congenital peripheral neuropathies disease
|
|
EP3083958B1
(en)
|
2013-12-19 |
2019-04-17 |
Amyris, Inc. |
Methods for genomic integration
|
|
US10233456B2
(en)
*
|
2014-01-30 |
2019-03-19 |
The Board Of Trustees Of The University Of Arkansas |
Method, vectors, cells, seeds and kits for stacking genes into a single genomic site
|
|
JP2017510542A
(ja)
|
2014-01-31 |
2017-04-13 |
ファクター バイオサイエンス インコーポレイテッド |
核酸生成及び送達のための方法及び製品
|
|
SI3102673T1
(sl)
|
2014-02-03 |
2020-11-30 |
Sangamo Therapeutics, Inc. |
Postopki in sestavki za zdravljenje beta talasemije
|
|
CN104844696A
(zh)
*
|
2014-02-19 |
2015-08-19 |
北京大学 |
一种转录激活子样效应因子功能蛋白设计、合成及其应用
|
|
TW201538518A
(zh)
|
2014-02-28 |
2015-10-16 |
Dow Agrosciences Llc |
藉由嵌合基因調控元件所賦予之根部特異性表現
|
|
SG11201609211VA
(en)
|
2014-03-05 |
2016-12-29 |
Nat Univ Corp Univ Kobe |
Genomic sequence modification method for specifically converting nucleic acid bases of targeted dna sequence, and molecular complex for use in same
|
|
CN106460009A
(zh)
|
2014-03-21 |
2017-02-22 |
小利兰·斯坦福大学托管委员会 |
无核酸酶的基因组编辑
|
|
JP6815986B2
(ja)
|
2014-03-26 |
2021-01-20 |
ユニバーシティ オブ メリーランド， カレッジ パーク |
大型家畜の接合体における標的化ゲノム編集
|
|
US10507232B2
(en)
*
|
2014-04-02 |
2019-12-17 |
University Of Florida Research Foundation, Incorporated |
Materials and methods for the treatment of latent viral infection
|
|
US9522936B2
(en)
|
2014-04-24 |
2016-12-20 |
Sangamo Biosciences, Inc. |
Engineered transcription activator like effector (TALE) proteins
|
|
BR122023023211A2
(pt)
|
2014-04-28 |
2024-01-23 |
Recombinetics, Inc. |
Método de fazer edições de genes multiplex em uma célula de vertebrado ou de embrião primário não-humano
|
|
US10563207B2
(en)
|
2014-04-30 |
2020-02-18 |
Tsinghua University |
Modular construction of synthetic gene circuits in mammalian cells using TALE transcriptional repressors
|
|
CN104611365B
(zh)
*
|
2014-07-17 |
2017-06-16 |
清华大学 |
利用tale转录抑制子在哺乳动物细胞中模块化构建合成基因线路
|
|
WO2015165276A1
(zh)
*
|
2014-04-30 |
2015-11-05 |
清华大学 |
利用tale转录抑制子在哺乳动物细胞中模块化构建合成基因线路的试剂盒
|
|
DE102014106327A1
(de)
|
2014-05-07 |
2015-11-12 |
Universitätsklinikum Hamburg-Eppendorf (UKE) |
TAL-Effektornuklease zum gezielten Knockout des HIV-Korezeptors CCR5
|
|
US11918695B2
(en)
|
2014-05-09 |
2024-03-05 |
Yale University |
Topical formulation of hyperbranched polymer-coated particles
|
|
EP4331618A3
(en)
|
2014-05-09 |
2024-06-12 |
Yale University |
Hyperbranched polyglycerol-coated particles and methods of making and using thereof
|
|
AU2015259191B2
(en)
|
2014-05-13 |
2019-03-21 |
Sangamo Therapeutics, Inc. |
Methods and compositions for prevention or treatment of a disease
|
|
HUE049776T2
(hu)
|
2014-06-06 |
2020-10-28 |
Regeneron Pharma |
Módszerek és készítmények egy célzott lókusz módosítására
|
|
WO2015188870A1
(en)
|
2014-06-12 |
2015-12-17 |
Sesvanderhave N.V. |
Use of selectable marker gene in sugar beet protoplasts transformation method and system
|
|
WO2015189409A1
(en)
|
2014-06-12 |
2015-12-17 |
Sesvanderhave N.V. |
Transformation method of sugar beet protoplasts by talen platform technology
|
|
WO2015193858A1
(en)
|
2014-06-20 |
2015-12-23 |
Cellectis |
Potatoes with reduced granule-bound starch synthase
|
|
MX384887B
(es)
|
2014-06-23 |
2025-03-14 |
Regeneron Pharma |
Ensamblaje de adn mediado por nucleasa.
|
|
EP3161128B1
(en)
|
2014-06-26 |
2018-09-26 |
Regeneron Pharmaceuticals, Inc. |
Methods and compositions for targeted genetic modifications and methods of use
|
|
WO2016000237A1
(en)
|
2014-07-03 |
2016-01-07 |
Pioneer Overseas Corporation |
Plants having enhanced tolerance to insect pests and related constructs and methods involving insect tolerance genes
|
|
CA2956224A1
(en)
|
2014-07-30 |
2016-02-11 |
President And Fellows Of Harvard College |
Cas9 proteins including ligand-dependent inteins
|
|
EP3179869A1
(en)
|
2014-08-11 |
2017-06-21 |
Evolva SA |
Production of steviol glycosides in recombinant hosts
|
|
CN107429241B
(zh)
|
2014-08-14 |
2025-10-24 |
百奥赛图(北京)医药科技股份有限公司 |
Dna敲入系统
|
|
CN105367628B
(zh)
*
|
2014-08-19 |
2019-07-26 |
深圳华大基因农业控股有限公司 |
一对高效编辑水稻waxy基因的talen其识别打靶位点及其应用
|
|
CN105367631B
(zh)
*
|
2014-08-25 |
2019-05-14 |
深圳华大基因科技有限公司 |
一种转录激活子样效应因子核酸酶及其编码基因和应用
|
|
WO2016037161A2
(en)
|
2014-09-07 |
2016-03-10 |
Selecta Biosciences, Inc. |
Methods and compositions for attenuating gene editing anti-viral transfer vector immune responses
|
|
JP2017528134A
(ja)
|
2014-09-09 |
2017-09-28 |
エヴォルヴァ エスアー．Ｅｖｏｌｖａ Ｓａ． |
組み換え宿主におけるステビオールグリコシドの生産
|
|
KR101528812B1
(ko)
*
|
2014-09-18 |
2015-06-15 |
강원대학교산학협력단 |
SETDB1 HMTase 발현 저해방법
|
|
CN105440111B
(zh)
*
|
2014-09-30 |
2019-08-13 |
深圳华大基因研究院 |
一对转录激活子样效应因子核酸酶及其编码序列与应用
|
|
JP6716577B2
(ja)
|
2014-10-01 |
2020-07-01 |
イーグル・バイオロジクス・インコーポレイテッドＥａｇｌｅ Ｂｉｏｌｏｇｉｃｓ， Ｉｎｃ． |
粘度低下物質を含有する、多糖および核酸の調合薬
|
|
CN104357440B
(zh)
*
|
2014-10-09 |
2017-06-13 |
中山大学 |
一对靶向斑马鱼Forkhead box n1基因的Talen识别序列及其mRNA制备方法
|
|
EP3204496A1
(en)
|
2014-10-10 |
2017-08-16 |
Editas Medicine, Inc. |
Compositions and methods for promoting homology directed repair
|
|
DK3207124T3
(da)
|
2014-10-15 |
2019-08-12 |
Regeneron Pharma |
Fremgangsmåder og sammensætninger til generering eller bevaring af pluripotente celler
|
|
WO2016066671A1
(en)
|
2014-10-29 |
2016-05-06 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Method for treating resistant cancers using progastrin inhibitors
|
|
DK3216867T3
(da)
|
2014-11-04 |
2020-06-22 |
Univ Kobe Nat Univ Corp |
Fremgangsmåde til at modificere genomsekvens for at introducere specifik mutation i tilsigtet dna-sekvens ved base-fjernelsesreaktion og molekylekompleks anvendt dertil
|
|
US20170369848A1
(en)
*
|
2014-11-11 |
2017-12-28 |
Q Therapeutics, Inc. |
Engineering mesenchymal stem cells using homologous recombination
|
|
DE102014016667B4
(de)
|
2014-11-12 |
2024-03-07 |
Kws Saat Se |
Haploideninduktoren
|
|
CN107105634A
(zh)
|
2014-11-12 |
2017-08-29 |
重组股份有限公司 |
肿瘤抑制基因的杂合修饰和1型神经纤维瘤病的猪模型
|
|
US20160138040A1
(en)
*
|
2014-11-13 |
2016-05-19 |
Cellectis |
Brassica engineered to confer herbicide tolerance
|
|
EP3889260A1
(en)
|
2014-12-12 |
2021-10-06 |
The Broad Institute, Inc. |
Protected guide rnas (pgrnas)
|
|
US20170327834A1
(en)
|
2014-12-15 |
2017-11-16 |
Syngenta Participations Ag |
Pesticidal microrna carriers and use thereof
|
|
JP6840077B2
(ja)
|
2014-12-19 |
2021-03-10 |
リジェネロン・ファーマシューティカルズ・インコーポレイテッドＲｅｇｅｎｅｒｏｎ Ｐｈａｒｍａｃｅｕｔｉｃａｌｓ， Ｉｎｃ． |
単一ステップの複数標的化を通じた標的化された遺伝子修飾のための方法及び組成物
|
|
CN107109427B
(zh)
|
2014-12-23 |
2021-06-18 |
先正达参股股份有限公司 |
用于鉴定和富集包含位点特异性基因组修饰的细胞的方法和组合物
|
|
CA2970370A1
(en)
|
2014-12-24 |
2016-06-30 |
Massachusetts Institute Of Technology |
Crispr having or associated with destabilization domains
|
|
US10752905B2
(en)
|
2015-01-20 |
2020-08-25 |
Mayo Foundation For Medical Education And Research |
Methods and materials for assembling nucleic acid constructs
|
|
EP3250680A4
(en)
|
2015-01-26 |
2018-12-05 |
Fate Therapeutics, Inc. |
Methods and compositions for inducing hematopoietic cell differentiation
|
|
EP3250686A1
(en)
|
2015-01-30 |
2017-12-06 |
Evolva SA |
Production of steviol glycosides in recombinant hosts
|
|
CA2975709A1
(en)
*
|
2015-02-02 |
2016-08-11 |
Cellectis |
Agrobacterium-mediated genome modification without t-dna integration
|
|
WO2016124920A1
(en)
|
2015-02-03 |
2016-08-11 |
The Institute Of Genetics And Developmental Biology |
Rice plants with altered seed phenotype and quality
|
|
US10793868B2
(en)
|
2015-02-03 |
2020-10-06 |
Institute Of Genetics And Developmental Biology Chinese Academy Of Sciences |
Plants with increased seed size
|
|
JP6929791B2
(ja)
|
2015-02-09 |
2021-09-01 |
デューク ユニバーシティ |
エピゲノム編集のための組成物および方法
|
|
WO2016128523A1
(en)
|
2015-02-12 |
2016-08-18 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Methods for predicting the responsiveness of a patient affected with malignant hematological disease to chemotherapy treatment and methods of treatment of such disease
|
|
EP3543339A1
(en)
|
2015-02-13 |
2019-09-25 |
Factor Bioscience Inc. |
Nucleic acid products and methods of administration thereof
|
|
JP6590333B2
(ja)
*
|
2015-02-26 |
2019-10-16 |
学校法人東京理科大学 |
Ｄｎａ結合ドメイン組込み用ベクターおよびそのセット、融合タンパク質コーディングベクターおよびそのセットならびにその製造方法、デスティネーションベクター、植物細胞用発現ベクターおよびその製造方法、植物細胞用発現ベクター作製用キット、形質転換方法、ならびにゲノム編集方法
|
|
WO2016138574A1
(en)
|
2015-03-02 |
2016-09-09 |
Sinai Health System |
Homologous recombination factors
|
|
WO2016142427A1
(en)
|
2015-03-10 |
2016-09-15 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Method ank kit for reprogramming somatic cells
|
|
KR102194612B1
(ko)
*
|
2015-03-16 |
2020-12-23 |
인스티튜트 오브 제네틱스 앤드 디벨롭멘털 바이오롤지, 차이니즈 아카데미 오브 사이언시스 |
비-유전성 물질을 이용한 식물 게놈의 부위-특이적인 변형 방법
|
|
CN115851470B
(zh)
|
2015-03-16 |
2025-09-02 |
帝斯曼知识产权资产管理有限公司 |
Udp-糖基转移酶
|
|
WO2016153305A1
(ko)
*
|
2015-03-26 |
2016-09-29 |
한국생명공학연구원 |
표적 유전자 특이적 핵산 프로브 및 Fok Ι 제한효소 이량체를 이용하여 세포 내에서 표적 유전자를 특이적으로 편집하기 위한 조성물 및 이의 용도
|
|
CA2981509A1
(en)
*
|
2015-03-30 |
2016-10-06 |
The Board Of Regents Of The Nevada System Of Higher Educ. On Behalf Of The University Of Nevada, La |
Compositions comprising talens and methods of treating hiv
|
|
ES2959608T3
(es)
|
2015-04-03 |
2024-02-27 |
Dana Farber Cancer Inst Inc |
Composición y métodos de edición del genoma de células B
|
|
EP3289080B1
(en)
|
2015-04-30 |
2021-08-25 |
The Trustees of Columbia University in the City of New York |
Gene therapy for autosomal dominant diseases
|
|
US11845928B2
(en)
|
2015-05-04 |
2023-12-19 |
Tsinghua University |
Methods and kits for fragmenting DNA
|
|
EP3095870A1
(en)
|
2015-05-19 |
2016-11-23 |
Kws Saat Se |
Methods for the in planta transformation of plants and manufacturing processes and products based and obtainable therefrom
|
|
WO2016205759A1
(en)
|
2015-06-18 |
2016-12-22 |
The Broad Institute Inc. |
Engineering and optimization of systems, methods, enzymes and guide scaffolds of cas9 orthologs and variants for sequence manipulation
|
|
MX392008B
(es)
|
2015-06-18 |
2025-03-21 |
Broad Inst Inc |
Mutaciones de la enzima crispr que reducen los efectos fuera del blanco
|
|
ES2594486B1
(es)
|
2015-06-19 |
2017-09-26 |
Biopraxis Research Aie |
Molécula de ácido nucleico, proteína de fusión y método para modificar el material genético de una célula
|
|
EP3316676A4
(en)
|
2015-06-30 |
2018-12-12 |
Regents of the University of Minnesota |
Haploid inducer line for accelerated genome editing
|
|
US10988775B2
(en)
|
2015-07-17 |
2021-04-27 |
Institute Of Genetics And Developmental Biology Chinese Academy Of Sciences |
Wheat plants resistant to powdery mildew
|
|
AU2016297167A1
(en)
*
|
2015-07-23 |
2018-02-22 |
Mayo Foundation For Medical Education And Research |
Editing mitochondrial DNA
|
|
AU2016307066A1
(en)
|
2015-08-07 |
2018-02-08 |
Evolva Sa |
Production of steviol glycosides in recombinant hosts
|
|
AU2016308339A1
(en)
|
2015-08-18 |
2018-04-12 |
Baylor College Of Medicine |
Methods and compositions for altering function and structure of chromatin loops and/or domains
|
|
US10898522B2
(en)
|
2015-08-19 |
2021-01-26 |
Children's Research Institute, Children's National Medical Center |
Compositions and methods for treating graft versus host disease
|
|
EP3348638B1
(en)
*
|
2015-09-09 |
2022-12-14 |
National University Corporation Kobe University |
Method for converting genome sequence of gram-positive bacterium by specifically converting nucleic acid base of targeted dna sequence, and molecular complex used in same
|
|
US10837024B2
(en)
|
2015-09-17 |
2020-11-17 |
Cellectis |
Modifying messenger RNA stability in plant transformations
|
|
US11970710B2
(en)
|
2015-10-13 |
2024-04-30 |
Duke University |
Genome engineering with Type I CRISPR systems in eukaryotic cells
|
|
EP3362074B1
(en)
|
2015-10-16 |
2023-08-09 |
President and Fellows of Harvard College |
Regulatory t cell pd-1 modulation for regulating t cell effector immune responses
|
|
EP4434589A3
(en)
|
2015-10-23 |
2025-05-14 |
President and Fellows of Harvard College |
Evolved cas9 proteins for gene editing
|
|
EP3673732A3
(en)
|
2015-10-27 |
2020-07-29 |
Recombinetics, Inc. |
Engineering of humanized car t-cells and platelets by genetic complementation
|
|
WO2017075329A2
(en)
|
2015-10-29 |
2017-05-04 |
Dana-Farber Cancer Institute, Inc. |
Methods for identification, assessment, prevention, and treatment of metabolic disorders using pm20d1 and n-lipidated amino acids
|
|
SG11201803145RA
(en)
|
2015-11-04 |
2018-05-30 |
Fate Therapeutics Inc |
Methods and compositions for inducing hematopoietic cell differentiation
|
|
WO2017079428A1
(en)
|
2015-11-04 |
2017-05-11 |
President And Fellows Of Harvard College |
Site specific germline modification
|
|
AU2016349504B2
(en)
|
2015-11-04 |
2023-02-09 |
Fate Therapeutics, Inc. |
Genomic engineering of pluripotent cells
|
|
WO2017087708A1
(en)
|
2015-11-19 |
2017-05-26 |
The Brigham And Women's Hospital, Inc. |
Lymphocyte antigen cd5-like (cd5l)-interleukin 12b (p40) heterodimers in immunity
|
|
EP3173485B1
(de)
|
2015-11-27 |
2021-08-25 |
KWS SAAT SE & Co. KGaA |
Kühletolerante pflanze
|
|
WO2017090761A1
(ja)
|
2015-11-27 |
2017-06-01 |
国立大学法人神戸大学 |
標的化したｄｎａ配列の核酸塩基を特異的に変換する、単子葉植物のゲノム配列の変換方法、及びそれに用いる分子複合体
|
|
KR102787119B1
(ko)
|
2015-11-30 |
2025-03-27 |
듀크 유니버시티 |
유전자 편집에 의한 인간 디스트로핀 유전자의 교정을 위한 치료용 표적 및 사용 방법
|
|
WO2017106528A2
(en)
|
2015-12-18 |
2017-06-22 |
Sangamo Biosciences, Inc. |
Targeted disruption of the t cell receptor
|
|
MX2018007519A
(es)
|
2015-12-18 |
2019-09-04 |
Sangamo Therapeutics Inc |
Alteracion dirigida del receptor celular del complejo mayor de histocompatibilidad (mhc).
|
|
DE102015017161A1
(de)
|
2015-12-21 |
2017-06-22 |
Kws Saat Se |
Restorer-Pflanze
|
|
US11840693B2
(en)
|
2015-12-21 |
2023-12-12 |
KWS SAAT SE & Co. KGaA |
Restorer plants
|
|
DE102015016445A1
(de)
|
2015-12-21 |
2017-06-22 |
Kws Saat Se |
Restorer-Pflanze
|
|
MX2018008344A
(es)
|
2016-01-11 |
2018-12-06 |
Univ Leland Stanford Junior |
Proteinas quimericas y metodos para regular la expresion genica.
|
|
JP7012645B2
(ja)
|
2016-01-11 |
2022-01-28 |
ザ ボード オブ トラスティーズ オブ ザ レランド スタンフォード ジュニア ユニバーシティー |
キメラタンパク質および免疫治療の方法
|
|
WO2017134601A1
(en)
|
2016-02-02 |
2017-08-10 |
Cellectis |
Modifying soybean oil composition through targeted knockout of the fad3a/b/c genes
|
|
AU2017221424A1
(en)
|
2016-02-16 |
2018-09-20 |
Yale University |
Compositions and methods for treatment of cystic fibrosis
|
|
EP3416976A2
(en)
|
2016-02-16 |
2018-12-26 |
Yale University |
Compositions for enhancing targeted gene editing and methods of use thereof
|
|
US20190249172A1
(en)
|
2016-02-18 |
2019-08-15 |
The Regents Of The University Of California |
Methods and compositions for gene editing in stem cells
|
|
CN116763942A
(zh)
|
2016-02-18 |
2023-09-19 |
宾州研究基金会 |
脑内生成gaba能神经元
|
|
WO2017144630A1
(en)
|
2016-02-26 |
2017-08-31 |
Cellectis |
Micelle based system nuclease encapsulation for in-vivo gene editing
|
|
JP2019515654A
(ja)
|
2016-03-16 |
2019-06-13 |
ザ ジェイ． デヴィッド グラッドストーン インスティテューツ |
肥満及び／又は糖尿病を処置するための方法及び組成物、並びに候補処置薬剤を識別するための方法及び組成物
|
|
WO2017165412A2
(en)
|
2016-03-21 |
2017-09-28 |
Dana-Farber Cancer Institute, Inc. |
T-cell exhaustion state-specific gene expression regulators and uses thereof
|
|
DK3433266T3
(da)
|
2016-03-23 |
2025-08-25 |
Univ California |
Fremgangsmåder til behandling af mitokondrieforstyrrelser
|
|
US20190117799A1
(en)
|
2016-04-01 |
2019-04-25 |
The Brigham And Women's Hospital, Inc. |
Stimuli-responsive nanoparticles for biomedical applications
|
|
MY198001A
(en)
|
2016-04-13 |
2023-07-25 |
Evolva SA |
Production of steviol glycoside in recombinant hosts
|
|
WO2017180711A1
(en)
|
2016-04-13 |
2017-10-19 |
Editas Medicine, Inc. |
Grna fusion molecules, gene editing systems, and methods of use thereof
|
|
US20190127713A1
(en)
|
2016-04-13 |
2019-05-02 |
Duke University |
Crispr/cas9-based repressors for silencing gene targets in vivo and methods of use
|
|
EP4711465A2
(en)
*
|
2016-04-14 |
2026-03-18 |
Fred Hutchinson Cancer Center |
Compositions and methods to program therapeutic cells using targeted nucleic acid nanocarriers
|
|
US10188749B2
(en)
|
2016-04-14 |
2019-01-29 |
Fred Hutchinson Cancer Research Center |
Compositions and methods to program therapeutic cells using targeted nucleic acid nanocarriers
|
|
WO2017178585A1
(en)
|
2016-04-15 |
2017-10-19 |
Cellectis |
A method of engineering drug-specific hypersensitive t-cells for immunotherapy by gene inactivation
|
|
CN107312788B
(zh)
*
|
2016-04-26 |
2020-07-28 |
中国科学院动物研究所 |
一种tale重复序列载体的构建方法
|
|
US11730826B2
(en)
|
2016-05-02 |
2023-08-22 |
Massachusetts Institute Of Technology |
Amphiphilic nanoparticles for delivery of CRISPR based therapy
|
|
US10815514B2
(en)
|
2016-05-16 |
2020-10-27 |
Evolva Sa |
Production of steviol glycosides in recombinant hosts
|
|
US11293033B2
(en)
|
2016-05-18 |
2022-04-05 |
Amyris, Inc. |
Compositions and methods for genomic integration of nucleic acids into exogenous landing pads
|
|
CN105950623B
(zh)
*
|
2016-05-19 |
2018-11-30 |
电子科技大学 |
一种用于talen高效构建的双rvd单元模块库及talen构建方法
|
|
EA201892624A1
(ru)
|
2016-05-26 |
2019-06-28 |
Нунхемс Б.В. |
Растения, дающие бессемянные плоды
|
|
US11293021B1
(en)
|
2016-06-23 |
2022-04-05 |
Inscripta, Inc. |
Automated cell processing methods, modules, instruments, and systems
|
|
EP3474849B1
(en)
|
2016-06-27 |
2025-05-21 |
The Broad Institute, Inc. |
Compositions and methods for detecting and treating diabetes
|
|
CA3029271A1
(en)
|
2016-06-28 |
2018-01-04 |
Cellectis |
Altering expression of gene products in plants through targeted insertion of nucleic acid sequences
|
|
CN105949293B
(zh)
*
|
2016-06-28 |
2019-08-13 |
福建农林大学 |
植物源高效转录激活功能域sac3及应用
|
|
WO2018007263A1
(en)
|
2016-07-06 |
2018-01-11 |
Cellectis |
Sequential gene editing in primary immune cells
|
|
CA3030587A1
(en)
|
2016-07-15 |
2018-01-18 |
Salk Institute For Biological Studies |
Methods and compositions for genome editing in non-dividing cells
|
|
EP4275747A3
(en)
|
2016-07-19 |
2024-01-24 |
Duke University |
Therapeutic applications of cpf1-based genome editing
|
|
RU2721125C1
(ru)
|
2016-07-29 |
2020-05-18 |
Регенерон Фармасьютикалз, Инк. |
Мыши, содержащие мутации, вследствие которых экспрессируется укороченный на с-конце фибриллин-1
|
|
JP7231935B2
(ja)
|
2016-08-03 |
2023-03-08 |
プレジデント アンド フェローズ オブ ハーバード カレッジ |
アデノシン核酸塩基編集因子およびそれらの使用
|
|
US11661590B2
(en)
|
2016-08-09 |
2023-05-30 |
President And Fellows Of Harvard College |
Programmable CAS9-recombinase fusion proteins and uses thereof
|
|
EP4056031A1
(en)
|
2016-08-11 |
2022-09-14 |
The Jackson Laboratory |
Methods and compositions relating to improved human red blood cell survival in genetically modified immunodeficient non-human animals
|
|
CN117604024A
(zh)
|
2016-08-17 |
2024-02-27 |
孟山都技术公司 |
通过操纵赤霉素代谢增加可收获产量的用于矮株型植物的方法和组合物
|
|
CA3033788A1
(en)
|
2016-08-17 |
2018-02-22 |
Factor Bioscience Inc. |
Nucleic acid products and methods of administration thereof
|
|
CA3034271A1
(en)
|
2016-08-18 |
2018-02-22 |
Cellectis |
Black-spot resistant potatoes with reduced tuber-specific polyphenol oxidase activity
|
|
SG11201901364VA
(en)
|
2016-08-24 |
2019-03-28 |
Sangamo Therapeutics Inc |
Engineered target specific nucleases
|
|
WO2018039438A1
(en)
|
2016-08-24 |
2018-03-01 |
President And Fellows Of Harvard College |
Incorporation of unnatural amino acids into proteins using base editing
|
|
EP3503927B1
(en)
|
2016-08-29 |
2025-02-19 |
The Regents of the University of California |
Topical formulations based on ionic species for skin treatment
|
|
US20200002709A1
(en)
|
2016-09-01 |
2020-01-02 |
Cellectis |
Methods for altering amino acid content in plants
|
|
WO2018049009A2
(en)
|
2016-09-07 |
2018-03-15 |
Sangamo Therapeutics, Inc. |
Modulation of liver genes
|
|
EP3515559B1
(en)
|
2016-09-20 |
2025-05-21 |
Dana-Farber Cancer Institute, Inc. |
Compositions and methods for identification, assessment, prevention, and treatment of aml using usp10 biomarkers and modulators
|
|
WO2018057790A1
(en)
|
2016-09-21 |
2018-03-29 |
Recombinetics, Inc. |
Animal models for cardiomyopathy
|
|
US20190225974A1
(en)
|
2016-09-23 |
2019-07-25 |
BASF Agricultural Solutions Seed US LLC |
Targeted genome optimization in plants
|
|
WO2018064208A1
(en)
|
2016-09-28 |
2018-04-05 |
The Broad Institute, Inc. |
Systematic screening and mapping of regulatory elements in non-coding genomic regions, methods, compositions, and applications thereof
|
|
ES2811500T3
(es)
|
2016-10-04 |
2021-03-12 |
Prec Biosciences Inc |
Dominios coestimuladores para su uso en células genéticamente modificadas
|
|
WO2018069232A1
(en)
|
2016-10-10 |
2018-04-19 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Methods for predicting the risk of having cardiac hypertrophy
|
|
CA3039935A1
(en)
|
2016-10-10 |
2018-04-19 |
Limagrain Europe |
Nucleic acid encoding sm1 resistance to orange wheat blossom midge and method of use
|
|
AU2017342543B2
(en)
|
2016-10-14 |
2024-06-27 |
President And Fellows Of Harvard College |
AAV delivery of nucleobase editors
|
|
GB201617559D0
(en)
|
2016-10-17 |
2016-11-30 |
University Court Of The University Of Edinburgh The |
Swine comprising modified cd163 and associated methods
|
|
WO2018073393A2
(en)
|
2016-10-19 |
2018-04-26 |
Cellectis |
Tal-effector nuclease (talen) -modified allogenic cells suitable for therapy
|
|
WO2018073391A1
(en)
|
2016-10-19 |
2018-04-26 |
Cellectis |
Targeted gene insertion for improved immune cells therapy
|
|
US20190249183A1
(en)
|
2016-10-24 |
2019-08-15 |
Javier Gil Humanes |
Multiplex gene targeting in plants
|
|
WO2018076335A1
(en)
|
2016-10-31 |
2018-05-03 |
Institute Of Genetics And Developmental Biology, Chinese Academy Of Sciences |
Compositions and methods for enhancing abiotic stress tolerance
|
|
WO2018144097A1
(en)
|
2016-11-04 |
2018-08-09 |
Akeagen Llc |
Genetically modified non-human animals and methods for producing heavy chain-only antibodies
|
|
US11396669B2
(en)
|
2016-11-07 |
2022-07-26 |
Evolva Sa |
Production of steviol glycosides in recombinant hosts
|
|
US12227578B2
(en)
|
2016-11-11 |
2025-02-18 |
The Broad Institute, Inc. |
Modulation of intestinal epithelial cell differentiation, maintenance and/or function through T cell action
|
|
WO2018092072A1
(en)
|
2016-11-16 |
2018-05-24 |
Cellectis |
Methods for altering amino acid content in plants through frameshift mutations
|
|
EP3546575B1
(en)
|
2016-11-28 |
2024-07-17 |
Osaka University |
Genome editing method
|
|
US10519456B2
(en)
|
2016-12-02 |
2019-12-31 |
Syngenta Participations Ag |
Simultaneous gene editing and haploid induction
|
|
CA3045134A1
(en)
|
2016-12-14 |
2018-06-21 |
Ligandal, Inc. |
Compositions and methods for nucleic acid and/or protein payload delivery
|
|
US20200085758A1
(en)
|
2016-12-16 |
2020-03-19 |
The Brigham And Women's Hospital, Inc. |
Co-delivery of nucleic acids for simultaneous suppression and expression of target genes
|
|
WO2018119359A1
(en)
|
2016-12-23 |
2018-06-28 |
President And Fellows Of Harvard College |
Editing of ccr5 receptor gene to protect against hiv infection
|
|
BR112019013072A2
(pt)
|
2016-12-27 |
2020-07-07 |
National Agriculture And Food Research Organization |
método para produzir planta editada pelo genoma
|
|
CA3049244A1
(en)
|
2017-01-05 |
2018-07-12 |
Fred Hutchinson Cancer Research Center |
Systems and methods to improve vaccine efficacy
|
|
GB201700380D0
(en)
|
2017-01-10 |
2017-02-22 |
Plant Bioscience Ltd |
Methods of increasing seed yield
|
|
WO2018136758A1
(en)
|
2017-01-23 |
2018-07-26 |
Regeneron Pharmaceuticals, Inc. |
Hsd17b13 variants and uses thereof
|
|
US12344826B2
(en)
|
2017-01-25 |
2025-07-01 |
The George Washington University, A Congressionally Chartered Not-For-Profit Corporation |
Apparatus and methods for in vitro preclinical human trials
|
|
AU2018218280B2
(en)
|
2017-02-07 |
2024-10-17 |
The Regents Of The University Of California |
Gene therapy for haploinsufficiency
|
|
US20190367937A1
(en)
|
2017-02-09 |
2019-12-05 |
Fujian Agriculture And Forestry University |
Expression of a phosphate transporter for improving plant yield
|
|
US11920148B2
(en)
|
2017-02-22 |
2024-03-05 |
Crispr Therapeutics Ag |
Compositions and methods for gene editing
|
|
EP3366778A1
(de)
|
2017-02-28 |
2018-08-29 |
Kws Saat Se |
Haploidisierung in sorghum
|
|
WO2018160485A1
(en)
|
2017-03-03 |
2018-09-07 |
Pioneer Hi-Bred International, Inc. |
Non-destructive assay for soybean seeds using near infrared analysis
|
|
US11898179B2
(en)
|
2017-03-09 |
2024-02-13 |
President And Fellows Of Harvard College |
Suppression of pain by gene editing
|
|
CN110662556A
(zh)
|
2017-03-09 |
2020-01-07 |
哈佛大学的校长及成员们 |
癌症疫苗
|
|
JP2020510439A
(ja)
|
2017-03-10 |
2020-04-09 |
プレジデント アンド フェローズ オブ ハーバード カレッジ |
シトシンからグアニンへの塩基編集因子
|
|
EP3599842B1
(en)
|
2017-03-21 |
2024-08-07 |
The Jackson Laboratory |
A genetically modified mouse expressing human apoe4 and mouse trem2.p.r47h and methods of use thereof
|
|
JP7133856B2
(ja)
|
2017-03-22 |
2022-09-09 |
国立大学法人神戸大学 |
細胞内在性のｄｎａ修飾酵素を利用して標的化したｄｎａの核酸塩基を特異的に変換する、細胞の核酸配列の変換方法、及びそれに用いる分子複合体
|
|
WO2018176009A1
(en)
|
2017-03-23 |
2018-09-27 |
President And Fellows Of Harvard College |
Nucleobase editors comprising nucleic acid programmable dna binding proteins
|
|
US12161694B2
(en)
|
2017-03-24 |
2024-12-10 |
The Broad Institute, Inc. |
Methods and compositions for regulating innate lymphoid cell inflammatory responses
|
|
WO2018172785A1
(en)
|
2017-03-24 |
2018-09-27 |
Institute Of Genetics And Developmental Biology, Chinese Academy Of Sciences |
Methods for increasing grain yield
|
|
US10980779B2
(en)
|
2017-03-24 |
2021-04-20 |
Inserm (Institut National De La Sante Et De La Recherche Medicale) |
GFI1 inhibitors for the treatment of hyperglycemia
|
|
JP7224645B2
(ja)
|
2017-03-30 |
2023-02-20 |
国立大学法人 東京大学 |
異なる複数の目的遺伝子の評価方法
|
|
US11963966B2
(en)
|
2017-03-31 |
2024-04-23 |
Dana-Farber Cancer Institute, Inc. |
Compositions and methods for treating ovarian tumors
|
|
US20200113821A1
(en)
|
2017-04-04 |
2020-04-16 |
Yale University |
Compositions and methods for in utero delivery
|
|
WO2018191553A1
(en)
|
2017-04-12 |
2018-10-18 |
Massachusetts Eye And Ear Infirmary |
Tumor signature for metastasis, compositions of matter methods of use thereof
|
|
WO2018191520A1
(en)
|
2017-04-12 |
2018-10-18 |
The Broad Institute, Inc. |
Respiratory and sweat gland ionocytes
|
|
EP3392339A1
(en)
|
2017-04-18 |
2018-10-24 |
Rheinisch-Westfälische Technische Hochschule (RWTH) Aachen |
Improved genome editing in plant cells
|
|
US12058986B2
(en)
|
2017-04-20 |
2024-08-13 |
Egenesis, Inc. |
Method for generating a genetically modified pig with inactivated porcine endogenous retrovirus (PERV) elements
|
|
WO2018195486A1
(en)
|
2017-04-21 |
2018-10-25 |
The Broad Institute, Inc. |
Targeted delivery to beta cells
|
|
CA3060622A1
(en)
|
2017-04-25 |
2018-11-01 |
Cellectis |
Alfalfa with reduced lignin composition
|
|
WO2018200943A1
(en)
|
2017-04-28 |
2018-11-01 |
Acuitas Therapeutics, Inc. |
Novel carbonyl lipids and lipid nanoparticle formulations for delivery of nucleic acids
|
|
CA3059793A1
(en)
|
2017-05-03 |
2018-11-08 |
Sangamo Therapeutics, Inc. |
Methods and compositions for modification of a cystic fibrosis transmembrane conductance regulator (cftr) gene
|
|
US11591601B2
(en)
|
2017-05-05 |
2023-02-28 |
The Broad Institute, Inc. |
Methods for identification and modification of lncRNA associated with target genotypes and phenotypes
|
|
WO2018208837A1
(en)
|
2017-05-08 |
2018-11-15 |
Precision Biosciences, Inc. |
Nucleic acid molecules encoding an engineered antigen receptor and an inhibitory nucleic acid molecule and methods of use thereof
|
|
US12226479B2
(en)
|
2017-05-11 |
2025-02-18 |
The General Hospital Corporation |
Methods and compositions of use of CD8+ tumor infiltrating lymphocyte subtypes and gene signatures thereof
|
|
US11560566B2
(en)
|
2017-05-12 |
2023-01-24 |
President And Fellows Of Harvard College |
Aptazyme-embedded guide RNAs for use with CRISPR-Cas9 in genome editing and transcriptional activation
|
|
CN110868850B
(zh)
|
2017-05-12 |
2023-07-14 |
杰克逊实验室 |
缺乏i类和ii类mhc的nsg小鼠
|
|
WO2018211032A1
(en)
|
2017-05-17 |
2018-11-22 |
Evolva Sa |
Production of steviol glycosides in recombinant hosts
|
|
CA3064817A1
(en)
|
2017-05-25 |
2018-11-29 |
Institute Of Genetics And Developmental Biology Chinese Academy Of Sciences |
Methods for increasing grain productivity
|
|
EP3409104A1
(en)
|
2017-05-31 |
2018-12-05 |
Vilmorin et Cie |
Tomato plant resistant to tomato yellow leaf curl virus, powdery mildew, and nematodes
|
|
EP3409106A1
(en)
|
2017-06-01 |
2018-12-05 |
Vilmorin et Cie |
Tolerance in plants of solanum lycopersicum to the tobamovirus tomato brown rugose fruit virus (tbrfv)
|
|
WO2020249996A1
(en)
|
2019-06-14 |
2020-12-17 |
Vilmorin & Cie |
Resistance in plants of solanum lycopersicum to the tobamovirus tomato brown rugose fruit virus
|
|
US11879128B2
(en)
|
2017-06-05 |
2024-01-23 |
Consejo Superior De Investigaciones Científicas (Csic)—Delegación Andalucía |
Targeting of gluten by genome editing
|
|
FI3635102T3
(fi)
|
2017-06-05 |
2025-10-28 |
Regeneron Pharma |
B4GALT1-variantteja ja niiden käyttöjä
|
|
EP3634496A4
(en)
|
2017-06-06 |
2021-09-08 |
Dana-Farber Cancer Institute, Inc. |
METHODS FOR SENSITIZING CANCER CELLS TO T-LYMPHOCYTES-MEDIA DESTRUCTION BY MODULATION OF MOLECULAR PATHWAYS
|
|
US11421208B2
(en)
|
2017-06-13 |
2022-08-23 |
Regents Of The University Of Minnesota |
Materials and methods for increasing gene editing frequency
|
|
WO2018232195A1
(en)
|
2017-06-14 |
2018-12-20 |
The Broad Institute, Inc. |
Compositions and methods targeting complement component 3 for inhibiting tumor growth
|
|
MX2019015188A
(es)
|
2017-06-15 |
2020-08-03 |
Univ California |
Inserciones de adn no virales orientadas.
|
|
US11512287B2
(en)
|
2017-06-16 |
2022-11-29 |
Sangamo Therapeutics, Inc. |
Targeted disruption of T cell and/or HLA receptors
|
|
EP3641785A1
(en)
|
2017-06-19 |
2020-04-29 |
Cellectis |
Anti-hbv combination therapies involving specific endonucleases
|
|
AU2018287042A1
(en)
|
2017-06-20 |
2020-02-06 |
Centre National De La Recherche Scientifique - Cnrs - |
Immune cells defective for Suv39h1
|
|
BR112019027710A2
(pt)
|
2017-06-23 |
2020-08-18 |
University Of Kentucky Research Foundation |
métodos de modulação do teor de alcaloides e do teor de uma nitrosamina específica do tabaco (tsna), uso de pelo menos um gene nic1 erf, método para produzir uma planta, planta modificada, material de propagação vegetal, uso de uma planta, folha colhida de uma planta, folha processada, material de tabaco curado, mistura de tabaco, produto da indústria do tabaco, produto de tabaco, uso de uma célula de tabaco, artigo de fumo combustível, uso de uma sequência de nucleotídeos, mutante de uma planta, progênie ou semente
|
|
US9982279B1
(en)
|
2017-06-23 |
2018-05-29 |
Inscripta, Inc. |
Nucleic acid-guided nucleases
|
|
US10011849B1
(en)
|
2017-06-23 |
2018-07-03 |
Inscripta, Inc. |
Nucleic acid-guided nucleases
|
|
AU2018290843B2
(en)
|
2017-06-26 |
2025-04-24 |
Massachusetts Institute Of Technology |
CRISPR/Cas-adenine deaminase based compositions, systems, and methods for targeted nucleic acid editing
|
|
AU2018291041B2
(en)
|
2017-06-30 |
2021-08-05 |
Inscripta, Inc. |
Automated cell processing methods, modules, instruments, and systems
|
|
CA3068465A1
(en)
|
2017-06-30 |
2019-01-03 |
Precision Biosciences, Inc. |
Genetically-modified t cells comprising a modified intron in the t cell receptor alpha gene
|
|
EP3652320B1
(en)
*
|
2017-07-12 |
2025-12-24 |
Mayo Foundation for Medical Education and Research |
Materials and methods for efficient targeted knock in or gene replacement
|
|
WO2019014581A1
(en)
|
2017-07-14 |
2019-01-17 |
The Broad Institute, Inc. |
METHODS AND COMPOSITIONS FOR MODULATING THE ACTIVITY OF A CYTOTOXIC LYMPHOCYTE
|
|
EP3654993A4
(en)
|
2017-07-17 |
2021-08-25 |
The Broad Institute, Inc. |
CELL ATLAS OF HEALTHY HUMAN COLUMN AND HUMAN COLUMN WITH COLITIS ULCEROSA
|
|
US11732274B2
(en)
|
2017-07-28 |
2023-08-22 |
President And Fellows Of Harvard College |
Methods and compositions for evolving base editors using phage-assisted continuous evolution (PACE)
|
|
EP3663310A4
(en)
*
|
2017-08-04 |
2021-08-11 |
Peking University |
TALE RVD SPECIFICALLY RECOGNIZING A DNA BASE MODIFIED BY METHYLATION AND CORRESPONDING APPLICATION
|
|
WO2019032675A1
(en)
|
2017-08-08 |
2019-02-14 |
Sangamo Therapeutics, Inc. |
CELL TARGETING MEDIATED BY A CHIMERIC ANTIGEN RECEPTOR
|
|
US20190045761A1
(en)
|
2017-08-11 |
2019-02-14 |
Recombinetics, Inc. |
Inducible disease models methods of making them and use in tissue complementation
|
|
EP3673054A4
(en)
|
2017-08-22 |
2021-06-02 |
Napigen, Inc. |
ORGANEL GENOME MODIFICATION USING POLYNUCLEOTIDE-GUIDED ENDONUCLEASE
|
|
EP3447134B1
(en)
|
2017-08-22 |
2023-10-11 |
KWS SAAT SE & Co. KGaA |
Increased fungal resistance in crop plants
|
|
WO2019038417A1
(en)
|
2017-08-25 |
2019-02-28 |
Institute Of Genetics And Developmental Biology, Chinese Academy Of Sciences |
METHODS FOR INCREASING GRAIN YIELD
|
|
US10738327B2
(en)
|
2017-08-28 |
2020-08-11 |
Inscripta, Inc. |
Electroporation cuvettes for automation
|
|
ES3038389T3
(en)
|
2017-08-29 |
2025-10-13 |
Kws Saat Se & Co Kgaa |
Improved blue aleurone and other segregation systems
|
|
WO2019139645A2
(en)
|
2017-08-30 |
2019-07-18 |
President And Fellows Of Harvard College |
High efficiency base editors comprising gam
|
|
EP3684940A1
(en)
|
2017-09-18 |
2020-07-29 |
Amyris, Inc. |
Methods for genetic engineering kluyveromyces host cells
|
|
CN111386343A
(zh)
|
2017-09-18 |
2020-07-07 |
阿迈瑞斯公司 |
用于克鲁维酵母宿主细胞基因组整合的方法
|
|
EP3684389A4
(en)
|
2017-09-21 |
2021-06-16 |
Dana Farber Cancer Institute, Inc. |
Isolation, preservation, compositions and uses of extracts from justicia plants
|
|
ES2962277T3
(es)
|
2017-09-29 |
2024-03-18 |
Regeneron Pharma |
Roedores que comprenden un locus Ttr humanizado y métodos de uso
|
|
US10435713B2
(en)
|
2017-09-30 |
2019-10-08 |
Inscripta, Inc. |
Flow through electroporation instrumentation
|
|
US20200239544A1
(en)
|
2017-10-03 |
2020-07-30 |
Precision Biosciences, Inc. |
Modified epidermal growth factor receptor peptides for use in genetically-modified cells
|
|
WO2019071054A1
(en)
|
2017-10-04 |
2019-04-11 |
The Broad Institute, Inc. |
METHODS AND COMPOSITIONS FOR MODIFYING THE FUNCTION AND STRUCTURE OF BUCKLES AND / OR CHROMATIN DOMAINS
|
|
AU2018347583A1
(en)
|
2017-10-13 |
2020-05-21 |
Selecta Biosciences, Inc. |
Methods and compositions for attenuating anti-viral transfer vector IgM responses
|
|
KR20200121782A
(ko)
|
2017-10-16 |
2020-10-26 |
더 브로드 인스티튜트, 인코퍼레이티드 |
아데노신 염기 편집제의 용도
|
|
CN111511903B
(zh)
|
2017-10-19 |
2024-10-11 |
塞勒克提斯公司 |
用于改善的免疫细胞疗法的nk抑制剂基因的靶向基因整合
|
|
JP7101419B2
(ja)
|
2017-10-27 |
2022-07-15 |
ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア |
内因性ｔ細胞受容体の標的置換
|
|
EP3704140A1
(en)
|
2017-10-31 |
2020-09-09 |
Vilmorin & Cie |
Wheat comprising male fertility restorer alleles
|
|
WO2019089913A1
(en)
|
2017-11-01 |
2019-05-09 |
Precision Biosciences, Inc. |
Engineered nucleases that target human and canine factor viii genes as a treatment for hemophilia a
|
|
EP3710039A4
(en)
|
2017-11-13 |
2021-08-04 |
The Broad Institute, Inc. |
METHODS AND COMPOSITIONS FOR TREATMENT OF CANCER BY TARGETING THE CLEC2D-KLRB1 PATH
|
|
US12171783B2
(en)
|
2017-11-13 |
2024-12-24 |
The Broad Institute, Inc. |
Methods and compositions for targeting developmental and oncogenic programs in H3K27M gliomas
|
|
WO2019094984A1
(en)
|
2017-11-13 |
2019-05-16 |
The Broad Institute, Inc. |
Methods for determining spatial and temporal gene expression dynamics during adult neurogenesis in single cells
|
|
WO2019100053A1
(en)
|
2017-11-20 |
2019-05-23 |
University Of Georgia Research Foundation, Inc. |
Compositions and methods for modulating hif-2α to improve muscle generation and repair
|
|
WO2019106163A1
(en)
|
2017-12-01 |
2019-06-06 |
Cellectis |
Reprogramming of genetically engineered primary immune cells
|
|
US12406749B2
(en)
|
2017-12-15 |
2025-09-02 |
The Broad Institute, Inc. |
Systems and methods for predicting repair outcomes in genetic engineering
|
|
JP2021506814A
(ja)
|
2017-12-15 |
2021-02-22 |
デイナ ファーバー キャンサー インスティチュート，インコーポレイテッド |
安定化ペプチドによって介在される標的タンパク質の分解
|
|
EP3728587A4
(en)
|
2017-12-18 |
2022-01-26 |
Syngenta Participations Ag |
SITES FOR TARGETED INSERTION IN THE MAIZE GENOME
|
|
DK3501268T3
(da)
|
2017-12-22 |
2021-11-08 |
Kws Saat Se & Co Kgaa |
Regenerering af planter i tilstedeværelse af histondeacetylase hæmmere
|
|
IL309585B2
(en)
|
2017-12-22 |
2025-03-01 |
Fate Therapeutics Inc |
Enhanced immune effector cells and use thereof
|
|
CN107868123B
(zh)
|
2017-12-25 |
2020-05-12 |
中国农业科学院作物科学研究所 |
一种同时提高植物产量和抗性的基因及其应用
|
|
EP3508581A1
(en)
|
2018-01-03 |
2019-07-10 |
Kws Saat Se |
Regeneration of genetically modified plants
|
|
US11994512B2
(en)
|
2018-01-04 |
2024-05-28 |
Massachusetts Institute Of Technology |
Single-cell genomic methods to generate ex vivo cell systems that recapitulate in vivo biology with improved fidelity
|
|
US20200362366A1
(en)
|
2018-01-12 |
2020-11-19 |
Basf Se |
Gene underlying the number of spikelets per spike qtl in wheat on chromosome 7a
|
|
JP7355742B2
(ja)
|
2018-01-18 |
2023-10-03 |
フレッド ハッチンソン キャンサー センター |
細胞活性状態を調節することにより免疫細胞の炎症状態をインビボで変更すること
|
|
US12509492B2
(en)
|
2018-01-19 |
2025-12-30 |
Duke University |
Genome engineering with CRISPR-Cas systems in eukaryotes
|
|
BR112020014242A2
(pt)
|
2018-02-14 |
2020-12-15 |
Institute Of Genetics And Developmental Biology, Chinese Academy Of Sciences |
Métodos de aumento da eficiência de uso de nutriente
|
|
US10881057B2
(en)
|
2018-02-15 |
2021-01-05 |
Monsanto Technology Llc |
Methods for hybrid corn seed production
|
|
CA3089883A1
(en)
|
2018-02-15 |
2019-08-22 |
Monsanto Technology Llc |
Compositions and methods for improving crop yields through trait stacking
|
|
US12178908B2
(en)
|
2018-02-26 |
2024-12-31 |
AnTolRx, Inc. |
Tolerogenic liposomes and methods of use thereof
|
|
CA3092073A1
(en)
|
2018-03-12 |
2019-09-19 |
Pioneer Hi-Bred International, Inc. |
Use of morphogenic factors for the improvement of gene editing
|
|
JP2021519067A
(ja)
|
2018-03-23 |
2021-08-10 |
ザ・トラスティーズ・オブ・コロンビア・ユニバーシティ・イン・ザ・シティ・オブ・ニューヨーク |
常染色体優性疾患のための遺伝子編集
|
|
KR102287880B1
(ko)
|
2018-03-26 |
2021-08-09 |
고쿠리츠다이가쿠호진 고베다이가쿠 |
세포에서 이중 가닥 dna의 표적 부위를 변형시키기 위한 방법
|
|
EP3545756A1
(en)
|
2018-03-28 |
2019-10-02 |
KWS SAAT SE & Co. KGaA |
Regeneration of plants in the presence of inhibitors of the histone methyltransferase ezh2
|
|
WO2019185920A1
(en)
|
2018-03-29 |
2019-10-03 |
Cellectis |
Tale-nucleases for allele-specific codon modification
|
|
EP3775228A4
(en)
|
2018-03-29 |
2022-02-23 |
Fate Therapeutics, Inc. |
ENHANCED IMMUNE EFFECTIVE CELLS AND THEIR USE
|
|
US10435662B1
(en)
|
2018-03-29 |
2019-10-08 |
Inscripta, Inc. |
Automated control of cell growth rates for induction and transformation
|
|
US20210155959A1
(en)
|
2018-04-06 |
2021-05-27 |
Children's Medical Center Corporation |
Compositions and methods for somatic cell reprogramming and modulating imprinting
|
|
EP3773658A4
(en)
|
2018-04-06 |
2022-04-27 |
Dana-Farber Cancer Institute, Inc. |
KIR3DL3 AS HLA2 RECEPTOR, ANTI-HHLA2 ANTIBODY AND ITS USES
|
|
GB201805865D0
(en)
|
2018-04-09 |
2018-05-23 |
Innes John Centre |
Genes
|
|
WO2019200004A1
(en)
|
2018-04-13 |
2019-10-17 |
Inscripta, Inc. |
Automated cell processing instruments comprising reagent cartridges
|
|
EP3781677A4
(en)
|
2018-04-16 |
2022-01-19 |
University of Massachusetts |
COMPOSITIONS AND METHODS FOR IMPROVED GENE EDITTING
|
|
CA3097648A1
(en)
|
2018-04-18 |
2019-10-24 |
Altius Institute For Biomedical Sciences |
Animal pathogen-derived polypeptides and uses thereof for genetic engineering
|
|
US10501738B2
(en)
|
2018-04-24 |
2019-12-10 |
Inscripta, Inc. |
Automated instrumentation for production of peptide libraries
|
|
EP3560330B1
(en)
|
2018-04-24 |
2022-06-15 |
KWS SAAT SE & Co. KGaA |
Plants with improved digestibility and marker haplotypes
|
|
US10858761B2
(en)
|
2018-04-24 |
2020-12-08 |
Inscripta, Inc. |
Nucleic acid-guided editing of exogenous polynucleotides in heterologous cells
|
|
US10557216B2
(en)
|
2018-04-24 |
2020-02-11 |
Inscripta, Inc. |
Automated instrumentation for production of T-cell receptor peptide libraries
|
|
TWI686477B
(zh)
|
2018-04-25 |
2020-03-01 |
國立成功大學 |
特異性造成植物葉綠體基因變異的轉殖載體、套組、方法及利用其產生之轉殖植物細胞與農桿菌
|
|
US11957695B2
(en)
|
2018-04-26 |
2024-04-16 |
The Broad Institute, Inc. |
Methods and compositions targeting glucocorticoid signaling for modulating immune responses
|
|
US12281301B2
(en)
|
2018-04-27 |
2025-04-22 |
The Broad Institute, Inc. |
Sequencing-based proteomics
|
|
US12012607B2
(en)
|
2018-05-02 |
2024-06-18 |
Cellectis |
Engineering wheat with increased dietary fiber
|
|
WO2019213660A2
(en)
|
2018-05-04 |
2019-11-07 |
The Broad Institute, Inc. |
Compositions and methods for modulating cgrp signaling to regulate innate lymphoid cell inflammatory responses
|
|
ES3047057T3
(en)
|
2018-05-09 |
2025-12-03 |
Kws Saat Se & Co Kgaa |
Gene for resistance to a pathogen of the genus heterodera
|
|
WO2019215500A1
(en)
|
2018-05-11 |
2019-11-14 |
Crispr Therapeutics Ag |
Methods and compositions for treating cancer
|
|
US12157760B2
(en)
|
2018-05-23 |
2024-12-03 |
The Broad Institute, Inc. |
Base editors and uses thereof
|
|
GB201808424D0
(en)
|
2018-05-23 |
2018-07-11 |
Lucite Int Uk Ltd |
Methods for producing BMA and MMA using genetically modified microorganisms
|
|
WO2019232542A2
(en)
|
2018-06-01 |
2019-12-05 |
Massachusetts Institute Of Technology |
Methods and compositions for detecting and modulating microenvironment gene signatures from the csf of metastasis patients
|
|
GB201809273D0
(en)
|
2018-06-06 |
2018-07-25 |
Vib Vzw |
Novel mutant plant cinnamoyl-coa reductase proteins
|
|
EP3802839A1
(en)
|
2018-06-07 |
2021-04-14 |
The State of Israel, Ministry of Agriculture & Rural Development, Agricultural Research Organization (ARO) (Volcani Center) |
Nucleic acid constructs and methods of using same
|
|
WO2019234750A1
(en)
|
2018-06-07 |
2019-12-12 |
The State Of Israel, Ministry Of Agriculture & Rural Development, Agricultural Research Organization (Aro) (Volcani Center) |
Methods of regenerating and transforming cannabis
|
|
CN112585261A
(zh)
|
2018-06-07 |
2021-03-30 |
布里格姆妇女医院 |
产生造血干细胞的方法
|
|
US12036240B2
(en)
|
2018-06-14 |
2024-07-16 |
The Broad Institute, Inc. |
Compositions and methods targeting complement component 3 for inhibiting tumor growth
|
|
EP3806619A1
(en)
|
2018-06-15 |
2021-04-21 |
Nunhems B.V. |
Seedless watermelon plants comprising modifications in an abc transporter gene
|
|
US12146142B2
(en)
|
2018-06-15 |
2024-11-19 |
KWS SAAT SE & Co. KGaA |
Methods for improving genome engineering and regeneration in plant II
|
|
EP3807300A1
(en)
|
2018-06-15 |
2021-04-21 |
KWS SAAT SE & Co. KGaA |
Methods for improving genome engineering and regeneration in plant
|
|
CA3103564A1
(en)
|
2018-06-15 |
2019-12-19 |
KWS SAAT SE & Co. KGaA |
Methods for enhancing genome engineering efficiency
|
|
EP3809838A4
(en)
|
2018-06-21 |
2022-03-23 |
The Jackson Laboratory |
GENETICALLY MODIFIED MOUSE MODELS OF ALZHEIMER'S DISEASE
|
|
WO2020006112A1
(en)
|
2018-06-26 |
2020-01-02 |
Regents Of The University Of Minnesota |
Delivery of developmental regulators to plants for the induction of meristematic tissue with genetic alterations
|
|
US12264181B2
(en)
|
2018-06-27 |
2025-04-01 |
Altius Institute For Biomedical Sciences |
Nucleic acid binding domains and methods of use thereof
|
|
WO2020005667A1
(en)
|
2018-06-29 |
2020-01-02 |
Pioneer Hi-Bred International, Inc. |
Compositions and methods for editing an endogenous nac gene in plants
|
|
WO2020005383A1
(en)
|
2018-06-30 |
2020-01-02 |
Inscripta, Inc. |
Instruments, modules, and methods for improved detection of edited sequences in live cells
|
|
CA3105331A1
(en)
|
2018-07-09 |
2020-01-16 |
Cellectis |
Canola with high oleic acid
|
|
US12522807B2
(en)
|
2018-07-09 |
2026-01-13 |
The Broad Institute, Inc. |
RNA programmable epigenetic RNA modifiers and uses thereof
|
|
US12247244B2
(en)
|
2018-07-31 |
2025-03-11 |
The University Of Tokyo |
Membrane protein activity measurement method
|
|
WO2020028617A1
(en)
|
2018-08-01 |
2020-02-06 |
University Of Georgia Research Foundation, Inc. |
Compositions and methods for improving embryo development
|
|
GB201812603D0
(en)
|
2018-08-02 |
2018-09-19 |
British American Tobacco Investments Ltd |
Method
|
|
JP2021533742A
(ja)
|
2018-08-07 |
2021-12-09 |
株式会社モダリス |
新規転写アクチベーター
|
|
EP3607819A1
(en)
|
2018-08-10 |
2020-02-12 |
Vilmorin et Cie |
Resistance to xanthomonas campestris pv. campestris (xcc) in cauliflower
|
|
US11142740B2
(en)
|
2018-08-14 |
2021-10-12 |
Inscripta, Inc. |
Detection of nuclease edited sequences in automated modules and instruments
|
|
US10532324B1
(en)
|
2018-08-14 |
2020-01-14 |
Inscripta, Inc. |
Instruments, modules, and methods for improved detection of edited sequences in live cells
|
|
WO2020041380A1
(en)
|
2018-08-20 |
2020-02-27 |
The Broad Institute, Inc. |
Methods and compositions for optochemical control of crispr-cas9
|
|
KR102712986B1
(ko)
|
2018-08-23 |
2024-10-07 |
상가모 테라퓨틱스, 인코포레이티드 |
조작된 표적 특이적 염기 편집기
|
|
CN113195715A
(zh)
|
2018-08-29 |
2021-07-30 |
阿迈瑞斯公司 |
基于选择的测定法的细胞和方法
|
|
CN109706155B
(zh)
*
|
2018-08-30 |
2022-04-19 |
南京农业大学 |
pOsHEN1::OsSPL14基因表达盒及其构建方法和应用
|
|
JP7682538B2
(ja)
|
2018-08-30 |
2025-05-26 |
ザ ユニバーシティ オブ ノース カロライナ アット チャペル ヒル |
フィードバック使用可能合成遺伝子、標的シードマッチカセット、およびその使用
|
|
CN112955540A
(zh)
|
2018-08-30 |
2021-06-11 |
因思科瑞普特公司 |
在自动化模块和仪器中对经核酸酶经编辑的序列的改进的检测
|
|
KR20210053930A
(ko)
|
2018-08-31 |
2021-05-12 |
예일 유니버시티 |
공여자 올리고뉴클레오티드 기반의 유전자 편집을 향상시키기 위한 조성물 및 방법
|
|
JP7570106B2
(ja)
|
2018-08-31 |
2024-10-21 |
イェール ユニバーシティー |
三重鎖およびヌクレアーゼベースの遺伝子編集を亢進するための組成物および方法
|
|
EP3623379A1
(en)
|
2018-09-11 |
2020-03-18 |
KWS SAAT SE & Co. KGaA |
Beet necrotic yellow vein virus (bnyvv)-resistance modifying gene
|
|
EP3849565A4
(en)
|
2018-09-12 |
2022-12-28 |
Fred Hutchinson Cancer Research Center |
REDUCTION OF CD33 EXPRESSION TO SELECTIVELY PROTECT THERAPEUTIC CELLS
|
|
AU2019344927A1
(en)
|
2018-09-18 |
2021-04-01 |
Sangamo Therapeutics, Inc. |
Programmed cell death 1 (PD1) specific nucleases
|
|
JP7344300B2
(ja)
|
2018-09-18 |
2023-09-13 |
ブイエヌブイ ニューコ インク． |
Ａｒｃベースのカプシドおよびその使用
|
|
MX2021003273A
(es)
*
|
2018-09-20 |
2021-07-16 |
Sanofi Sa |
Metodos y composiciones de clonacion universal basados en intrones.
|
|
EP4613367A1
(en)
|
2018-09-21 |
2025-09-10 |
Acuitas Therapeutics, Inc. |
Systems and methods for manufacturing lipid nanoparticles and liposomes
|
|
GB201815672D0
(en)
|
2018-09-26 |
2018-11-07 |
Innes John Centre |
Methods for altering starch granule size profile
|
|
CN112867794B
(zh)
|
2018-10-04 |
2025-02-18 |
株式会社钟化 |
用于植物的基因组编辑的dna构建物
|
|
WO2020077236A1
(en)
|
2018-10-12 |
2020-04-16 |
The Broad Institute, Inc. |
Method for extracting nuclei or whole cells from formalin-fixed paraffin-embedded tissues
|
|
CA3116452A1
(en)
|
2018-10-15 |
2020-04-23 |
Fondazione Telethon |
Genome editing methods and constructs
|
|
EP3866583A1
(en)
|
2018-10-16 |
2021-08-25 |
Pioneer Hi-Bred International, Inc. |
Genome edited fine mapping and causal gene identification
|
|
WO2020081730A2
(en)
|
2018-10-16 |
2020-04-23 |
Massachusetts Institute Of Technology |
Methods and compositions for modulating microenvironment
|
|
CA3116334A1
(en)
|
2018-10-22 |
2020-04-30 |
University Of Rochester |
Genome editing by directed non-homologous dna insertion using a retroviral integrase-cas9 fusion protein
|
|
EP3870697A4
(en)
|
2018-10-22 |
2022-11-09 |
Inscripta, Inc. |
GMO ENZYMES
|
|
US11214781B2
(en)
|
2018-10-22 |
2022-01-04 |
Inscripta, Inc. |
Engineered enzyme
|
|
WO2020092453A1
(en)
|
2018-10-29 |
2020-05-07 |
The Broad Institute, Inc. |
Nucleobase editors comprising geocas9 and uses thereof
|
|
WO2020092839A1
(en)
|
2018-10-31 |
2020-05-07 |
Mayo Foundation For Medical Education And Research |
Methods and materials for treating cancer
|
|
US12257286B2
(en)
|
2018-10-31 |
2025-03-25 |
Mayo Foundation For Medical Education And Research |
Methods and materials for treating cancer
|
|
GB201817971D0
(en)
|
2018-11-02 |
2018-12-19 |
British American Tobacco Investments Ltd |
Method
|
|
CA3118453A1
(en)
|
2018-11-02 |
2020-05-07 |
The Regents Of The University Of California |
Compositions and methods for treating brain injury
|
|
CN113015750A
(zh)
|
2018-11-07 |
2021-06-22 |
克里斯珀医疗股份公司 |
抗liv1免疫细胞癌症疗法
|
|
CN113227141A
(zh)
|
2018-11-07 |
2021-08-06 |
克里斯珀医疗股份公司 |
抗cd33免疫细胞癌症疗法
|
|
US12146157B2
(en)
|
2018-11-07 |
2024-11-19 |
Crispr Therapeutics Ag |
Anti-PTK7 immune cell cancer therapy
|
|
US12402610B2
(en)
|
2018-11-09 |
2025-09-02 |
The Broad Institute, Inc. |
Methods and compositions for modulating innate lymphoid cell pathogenic effectors
|
|
US12165743B2
(en)
|
2018-11-09 |
2024-12-10 |
The Broad Institute, Inc. |
Compressed sensing for screening and tissue imaging
|
|
GB201818715D0
(en)
|
2018-11-16 |
2019-01-02 |
British American Tobacco Investments Ltd |
Method
|
|
US12227548B2
(en)
|
2018-11-19 |
2025-02-18 |
Dana-Farber Cancer Institute, Inc. |
Use of IRE1α-XBP1 signaling pathway biomarkers for modulating immune responses
|
|
WO2020112647A1
(en)
|
2018-11-27 |
2020-06-04 |
Khona Scientific Llc |
Bidirectional multi-enzymatic scaffolds for biosynthesizing cannabinoids
|
|
WO2020112195A1
(en)
|
2018-11-30 |
2020-06-04 |
Yale University |
Compositions, technologies and methods of using plerixafor to enhance gene editing
|
|
WO2020117526A1
(en)
|
2018-12-02 |
2020-06-11 |
Fate Therapeutics, Inc. |
IMMUNOTHERAPIES USING ENHANCED iPSC DERIVED EFFECTOR CELLS
|
|
JOP20210133A1
(ar)
|
2018-12-05 |
2023-01-30 |
Vertex Pharma |
أنظمة تعديل جيني لتعديل جين منظم لموصلية التليف الكيسي عبر الغشاء (cftr)
|
|
KR20200071198A
(ko)
|
2018-12-10 |
2020-06-19 |
네오이뮨텍, 인코퍼레이티드 |
Nrf2 발현 조절 기반 T 세포 항암면역치료법
|
|
GB201820109D0
(en)
|
2018-12-11 |
2019-01-23 |
Vib Vzw |
Plants with a lignin trait and udp-glycosyltransferase mutation
|
|
US12274205B2
(en)
|
2018-12-12 |
2025-04-15 |
Monsanto Technology Llc |
Delayed harvest of short stature corn plants
|
|
CN113544266A
(zh)
|
2018-12-17 |
2021-10-22 |
博德研究所 |
Crispr相关转座酶系统和其使用方法
|
|
US11690362B2
(en)
|
2018-12-20 |
2023-07-04 |
Regeneran Pharmaceuticals, Inc. |
Nuclease-mediated repeat expansion
|
|
EP3898661A1
(en)
|
2018-12-21 |
2021-10-27 |
Precision BioSciences, Inc. |
Genetic modification of the hydroxyacid oxidase 1 gene for treatment of primary hyperoxaluria
|
|
US11739156B2
(en)
|
2019-01-06 |
2023-08-29 |
The Broad Institute, Inc. Massachusetts Institute of Technology |
Methods and compositions for overcoming immunosuppression
|
|
CA3125485A1
(en)
|
2019-01-11 |
2020-07-16 |
Acuitas Therapeutics, Inc. |
Lipids for lipid nanoparticle delivery of active agents
|
|
CA3126761C
(en)
|
2019-01-15 |
2023-01-10 |
Seminis Vegetable Seeds, Inc. |
Green bean plants with improved disease resistance
|
|
US12156877B1
(en)
|
2019-01-15 |
2024-12-03 |
The Regents Of The University Of California |
Methods of treating conditions related to a thiamine deficiency, a thiamine-dependent enzyme, or an associated cofactor
|
|
GB201900940D0
(en)
|
2019-01-23 |
2019-03-13 |
British American Tobacco Investments Ltd |
Method
|
|
WO2020154500A1
(en)
|
2019-01-23 |
2020-07-30 |
The Broad Institute, Inc. |
Supernegatively charged proteins and uses thereof
|
|
US20220112511A1
(en)
|
2019-01-29 |
2022-04-14 |
The University Of Warwick |
Methods for enhancing genome engineering efficiency
|
|
WO2020161261A1
(en)
|
2019-02-06 |
2020-08-13 |
Vilmorin & Cie |
New gene responsible for cytoplasmic male sterility
|
|
US20230053540A1
(en)
|
2019-02-19 |
2023-02-23 |
Massachusetts Institute Of Technology |
Treatment of liver injury
|
|
WO2020178193A1
(en)
|
2019-03-01 |
2020-09-10 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Method of treatment of sarcoidosis
|
|
SG11202109550TA
(en)
|
2019-03-07 |
2021-09-29 |
Univ Columbia |
Rna-guided dna integration using tn7-like transposons
|
|
EP3708651A1
(en)
|
2019-03-12 |
2020-09-16 |
KWS SAAT SE & Co. KGaA |
Improving plant regeneration
|
|
WO2020186237A1
(en)
|
2019-03-13 |
2020-09-17 |
The Broad Institute, Inc. |
Microglial progenitors for regeneration of functional microglia in the central nervous system and therapeutics uses thereof
|
|
MX2021011426A
(es)
|
2019-03-19 |
2022-03-11 |
Broad Inst Inc |
Metodos y composiciones para editar secuencias de nucleótidos.
|
|
AU2020247900A1
(en)
|
2019-03-25 |
2021-11-04 |
Inscripta, Inc. |
Simultaneous multiplex genome editing in yeast
|
|
US11001831B2
(en)
|
2019-03-25 |
2021-05-11 |
Inscripta, Inc. |
Simultaneous multiplex genome editing in yeast
|
|
AU2020256225B9
(en)
|
2019-04-03 |
2025-04-10 |
Regeneron Pharmaceuticals, Inc. |
Methods and compositions for insertion of antibody coding sequences into a safe harbor locus
|
|
KR20240122580A
(ko)
|
2019-04-03 |
2024-08-12 |
프리시젼 바이오사이언시스 인코포레이티드 |
마이크로RNA-적응 shRNA(shRNAmiR)를 포함하는 유전자-변형 면역 세포
|
|
US11111504B2
(en)
|
2019-04-04 |
2021-09-07 |
Regeneron Pharmaceuticals, Inc. |
Methods for scarless introduction of targeted modifications into targeting vectors
|
|
WO2020206139A1
(en)
|
2019-04-04 |
2020-10-08 |
Regeneron Pharmaceuticals, Inc. |
Non-human animals comprising a humanized coagulation factor 12 locus
|
|
US20220204994A1
(en)
|
2019-04-05 |
2022-06-30 |
Precision Biosciences, Inc. |
Methods of preparing populations of genetically-modified immune cells
|
|
US20220186263A1
(en)
|
2019-04-05 |
2022-06-16 |
Osaka University |
Method for producing knock-in cell
|
|
WO2020214842A1
(en)
|
2019-04-17 |
2020-10-22 |
The Broad Institute, Inc. |
Adenine base editors with reduced off-target effects
|
|
UA128175C2
(uk)
|
2019-05-13 |
2024-04-24 |
Квс Саат Се Енд Ко. Кгаа |
Посухостійкість у кукурудзи
|
|
GB201906768D0
(en)
|
2019-05-14 |
2019-06-26 |
British American Tobacco Investments Ltd |
Method
|
|
EP3969466A4
(en)
|
2019-05-14 |
2023-01-18 |
Yield10 Bioscience, Inc. |
MODIFIED PLANTS WITH A POLYNUCLEOTIDE WITH AN UNRELATED PROMOTER OPERATIONALLY LINKED TO AN CODING SEQUENCE THAT ENCODES A TRANSCRIPTION FACTOR
|
|
WO2020234426A1
(en)
|
2019-05-23 |
2020-11-26 |
Nanjing Agricultural University |
Methods for improving rice grain yield
|
|
AR118995A1
(es)
|
2019-05-25 |
2021-11-17 |
Kws Saat Se & Co Kgaa |
Mejorador de la inducción de haploides
|
|
WO2020243261A1
(en)
|
2019-05-28 |
2020-12-03 |
Selecta Biosciences, Inc. |
Methods and compositions for attenuated anti-viral transfer vector immune response
|
|
WO2020243371A1
(en)
|
2019-05-28 |
2020-12-03 |
Massachusetts Institute Of Technology |
Methods and compositions for modulating immune responses
|
|
US20220243178A1
(en)
|
2019-05-31 |
2022-08-04 |
The Broad Institute, Inc. |
Methods for treating metabolic disorders by targeting adcy5
|
|
EP3801011A1
(en)
|
2019-06-04 |
2021-04-14 |
Regeneron Pharmaceuticals, Inc. |
Non-human animals comprising a humanized ttr locus with a beta-slip mutation and methods of use
|
|
WO2020244759A1
(en)
|
2019-06-05 |
2020-12-10 |
Klemm & Sohn Gmbh & Co. Kg |
New plants having a white foliage phenotype
|
|
WO2020247587A1
(en)
|
2019-06-06 |
2020-12-10 |
Inscripta, Inc. |
Curing for recursive nucleic acid-guided cell editing
|
|
AU2020289581B2
(en)
|
2019-06-07 |
2024-11-21 |
Regeneron Pharmaceuticals, Inc. |
Non-human animals comprising a humanized albumin locus
|
|
CN114258398A
(zh)
|
2019-06-13 |
2022-03-29 |
总医院公司 |
工程化的人内源性病毒样颗粒及使用其递送至细胞的方法
|
|
CA3137765A1
(en)
|
2019-06-14 |
2020-12-17 |
Regeneron Pharmaceuticals, Inc. |
Models of tauopathy
|
|
EP3987024A4
(en)
|
2019-06-20 |
2023-11-01 |
University Of Massachusetts |
COMPOSITIONS AND METHODS FOR ENHANCED GENOMIC EDITING
|
|
WO2020254850A1
(en)
|
2019-06-21 |
2020-12-24 |
Vilmorin & Cie |
Improvement of quality and permanence of green color of peppers at maturity and over-maturity
|
|
EP3986909A4
(en)
|
2019-06-21 |
2023-08-02 |
Inscripta, Inc. |
Genome-wide rationally-designed mutations leading to enhanced lysine production in e. coli
|
|
US10927385B2
(en)
|
2019-06-25 |
2021-02-23 |
Inscripta, Inc. |
Increased nucleic-acid guided cell editing in yeast
|
|
BR112021026382A2
(pt)
|
2019-06-27 |
2022-02-08 |
Crispr Therapeutics Ag |
Uso de células t de receptor de antígenos quimérico e inibidores de células nk para tratamento de câncer
|
|
EP3757219A1
(en)
|
2019-06-28 |
2020-12-30 |
KWS SAAT SE & Co. KGaA |
Enhanced plant regeneration and transformation by using grf1 booster gene
|
|
GB201909562D0
(en)
|
2019-07-03 |
2019-08-14 |
British American Tobacco Investments Ltd |
Method
|
|
GB201909563D0
(en)
|
2019-07-03 |
2019-08-14 |
British American Tobacco Investments Ltd |
Method
|
|
US12344572B2
(en)
|
2019-07-03 |
2025-07-01 |
Factor Bioscience Inc. |
Cationic lipids and transfection methods
|
|
EP3993612A1
(en)
|
2019-07-05 |
2022-05-11 |
Limagrain Europe |
Method for increasing yield in plants
|
|
AR122277A1
(es)
|
2019-07-11 |
2022-08-31 |
Univ California |
Métodos para la regeneración mejorada de plantas transgénicas utilizando el factor de regulación del crecimiento (grf), el factor de interacción con grf (gif) o genes grf-gif y proteínas quiméricos
|
|
JP2022541441A
(ja)
|
2019-07-17 |
2022-09-26 |
フェイト セラピューティクス，インコーポレイテッド |
免疫エフェクター細胞操作およびその使用
|
|
US20220251572A1
(en)
|
2019-07-23 |
2022-08-11 |
Mnemo Therapeutics |
Immune cells defective for suv39h1
|
|
FR3099178A1
(fr)
|
2019-07-24 |
2021-01-29 |
Soltis |
Tournesol à teneur élevée en acide oléique et procédé d’obtention
|
|
WO2021016608A1
(en)
|
2019-07-25 |
2021-01-28 |
Precision Biosciences, Inc. |
Compositions and methods for sequential stacking of nucleic acid sequences into a genomic locus
|
|
US10501404B1
(en)
|
2019-07-30 |
2019-12-10 |
Factor Bioscience Inc. |
Cationic lipids and transfection methods
|
|
WO2021022043A2
(en)
|
2019-07-30 |
2021-02-04 |
Pairwise Plants Services, Inc. |
Morphogenic regulators and methods of using the same
|
|
WO2021019272A1
(en)
|
2019-07-31 |
2021-02-04 |
Vilmorin & Cie |
Tolerance to tolcndv in cucumber
|
|
EP3772542A1
(en)
|
2019-08-07 |
2021-02-10 |
KWS SAAT SE & Co. KGaA |
Modifying genetic variation in crops by modulating the pachytene checkpoint protein 2
|
|
CA3148179A1
(en)
|
2019-08-20 |
2021-02-25 |
Bruce J. Mccreedy Jr. |
Lymphodepletion dosing regimens for cellular immunotherapies
|
|
WO2021035170A1
(en)
|
2019-08-21 |
2021-02-25 |
Precision Biosciences, Inc. |
Compositions and methods for tcr reprogramming using fusion proteins
|
|
AU2020336992A1
(en)
|
2019-08-30 |
2022-04-14 |
Yale University |
Compositions and methods for delivery of nucleic acids to cells
|
|
US20220298501A1
(en)
|
2019-08-30 |
2022-09-22 |
The Broad Institute, Inc. |
Crispr-associated mu transposase systems
|
|
CN114729325A
(zh)
|
2019-09-06 |
2022-07-08 |
克里斯珀医疗股份公司 |
在培养物中具有改善的持久性的基因工程化t细胞
|
|
CA3147643A1
(en)
|
2019-09-23 |
2021-04-01 |
Omega Therapeutics, Inc. |
Compositions and methods for modulating hepatocyte nuclear factor 4-alpha (hnf4.alpha.) gene expression
|
|
EP4048807A1
(en)
|
2019-09-23 |
2022-08-31 |
Omega Therapeutics, Inc. |
Compositions and methods for modulating apolipoprotein b (apob) gene expression
|
|
SG10202008262UA
(en)
|
2019-09-26 |
2021-04-29 |
Seminis Vegetable Seeds Inc |
Lettuce plants having resistance to nasonovia ribisnigri biotype nr:1
|
|
GB201914137D0
(en)
|
2019-10-01 |
2019-11-13 |
Univ Leeds Innovations Ltd |
Modified Plants
|
|
US11981922B2
(en)
|
2019-10-03 |
2024-05-14 |
Dana-Farber Cancer Institute, Inc. |
Methods and compositions for the modulation of cell interactions and signaling in the tumor microenvironment
|
|
US12435330B2
(en)
|
2019-10-10 |
2025-10-07 |
The Broad Institute, Inc. |
Methods and compositions for prime editing RNA
|
|
EP3808170A1
(en)
|
2019-10-17 |
2021-04-21 |
Bejo Zaden B.V. |
Lactuca sativa resistance to bremia lactucae
|
|
US20230357788A1
(en)
|
2019-10-17 |
2023-11-09 |
KWS SAAT SE & Co. KGaA |
Enhanced disease resistance of crops by downregulation of repressor genes
|
|
US20220411479A1
(en)
|
2019-10-30 |
2022-12-29 |
Precision Biosciences, Inc. |
Cd20 chimeric antigen receptors and methods of use for immunotherapy
|
|
CN121109454A
(zh)
|
2019-11-06 |
2025-12-12 |
青岛清原化合物有限公司 |
在生物体内创制新基因的方法及应用
|
|
AU2020379046B2
(en)
|
2019-11-08 |
2025-03-13 |
Regeneron Pharmaceuticals, Inc. |
CRISPR and AAV strategies for X-linked juvenile retinoschisis therapy
|
|
CN115335528A
(zh)
|
2019-11-12 |
2022-11-11 |
科沃施种子欧洲股份两合公司 |
孢囊线虫属病原体抗性基因
|
|
JP7448120B2
(ja)
|
2019-11-14 |
2024-03-12 |
国立研究開発法人農業・食品産業技術総合研究機構 |
プラズマを用いてゲノム編集酵素を植物細胞内に導入する方法
|
|
WO2021094805A1
(en)
|
2019-11-14 |
2021-05-20 |
Vilmorin & Cie |
Resistance to acidovorax valerianellae in corn salad
|
|
CN114901812A
(zh)
|
2019-11-14 |
2022-08-12 |
国立大学法人广岛大学 |
使用环状dna将抗原特异性受体基因导入至t细胞基因组的方法
|
|
US11203762B2
(en)
|
2019-11-19 |
2021-12-21 |
Inscripta, Inc. |
Methods for increasing observed editing in bacteria
|
|
WO2021108363A1
(en)
|
2019-11-25 |
2021-06-03 |
Regeneron Pharmaceuticals, Inc. |
Crispr/cas-mediated upregulation of humanized ttr allele
|
|
WO2021108248A1
(en)
|
2019-11-27 |
2021-06-03 |
Calyxt, Inc. |
Tal-effector nucleases for gene editing
|
|
US20230036065A1
(en)
|
2019-12-06 |
2023-02-02 |
Precision Biosciences, Inc. |
Methods for cancer immunotherapy
|
|
CN114787347B
(zh)
|
2019-12-10 |
2024-07-12 |
因思科瑞普特公司 |
新颖的mad核酸酶
|
|
US10704033B1
(en)
|
2019-12-13 |
2020-07-07 |
Inscripta, Inc. |
Nucleic acid-guided nucleases
|
|
EP3835309A1
(en)
|
2019-12-13 |
2021-06-16 |
KWS SAAT SE & Co. KGaA |
Method for increasing cold or frost tolerance in a plant
|
|
CN114787362A
(zh)
|
2019-12-13 |
2022-07-22 |
中外制药株式会社 |
检测细胞外嘌呤受体配体的系统和导入该系统的非人动物
|
|
CN113061626B
(zh)
*
|
2019-12-16 |
2024-01-19 |
中国科学院脑科学与智能技术卓越创新中心 |
一种组织特异性敲除斑马鱼基因的方法及应用
|
|
CA3157127A1
(en)
|
2019-12-18 |
2021-06-24 |
Aamir MIR |
Cascade/dcas3 complementation assays for in vivo detection of nucleic acid-guided nuclease edited cells
|
|
GB201918902D0
(en)
|
2019-12-19 |
2020-02-05 |
Genome Res Ltd |
Cell differentiation
|
|
US10689669B1
(en)
|
2020-01-11 |
2020-06-23 |
Inscripta, Inc. |
Automated multi-module cell processing methods, instruments, and systems
|
|
US12165747B2
(en)
|
2020-01-23 |
2024-12-10 |
The Broad Institute, Inc. |
Molecular spatial mapping of metastatic tumor microenvironment
|
|
US11225674B2
(en)
|
2020-01-27 |
2022-01-18 |
Inscripta, Inc. |
Electroporation modules and instrumentation
|
|
JP2023519087A
(ja)
|
2020-01-31 |
2023-05-10 |
カリックス インコーポレイテッド |
ダイズにおける飽和脂肪の増加
|
|
EP4100525A1
(en)
|
2020-02-05 |
2022-12-14 |
Institut National de la Santé et de la Recherche Médicale (INSERM) |
Methods of treatment of cancer disease by targeting an epigenetic factor
|
|
WO2021158915A1
(en)
|
2020-02-06 |
2021-08-12 |
Precision Biosciences, Inc. |
Recombinant adeno-associated virus compositions and methods for producing and using the same
|
|
CA3167262A1
(en)
|
2020-02-24 |
2021-09-02 |
Pioneer Hi-Bred International, Inc. |
Intra-genomic homologous recombination
|
|
CA3169128A1
(en)
|
2020-02-28 |
2021-09-02 |
Ling MENG |
Immature inflorescence meristem editing
|
|
AU2021226415A1
(en)
|
2020-02-28 |
2022-09-15 |
Pioneer Hi-Bred International, Inc. |
Sorghum doubled haploid production system
|
|
JP2023515671A
(ja)
|
2020-03-04 |
2023-04-13 |
リジェネロン・ファーマシューティカルズ・インコーポレイテッド |
免疫療法に対する腫瘍細胞の感作のための方法及び組成物
|
|
WO2021183636A1
(en)
|
2020-03-10 |
2021-09-16 |
Calyxt, Inc. |
Transformation and regeneration of cannabaceae
|
|
EP4118207A1
(en)
|
2020-03-11 |
2023-01-18 |
Omega Therapeutics, Inc. |
Compositions and methods for modulating forkhead box p3 (foxp3) gene expression
|
|
EP4129050A4
(en)
|
2020-03-26 |
2024-05-08 |
National Agriculture And Food Research Organization |
METHOD FOR PRODUCING A TEMPERATURE SENSITIVE MALE STERILE PLANT
|
|
WO2021191870A1
(en)
|
2020-03-27 |
2021-09-30 |
Dcprime B.V. |
Ex vivo use of modified cells of leukemic origin for enhancing the efficacy of adoptive cell therapy
|
|
WO2021202648A1
(en)
|
2020-03-31 |
2021-10-07 |
Calyxt, Inc. |
Agrobacterium-mediated infiltration of cannabaceae
|
|
US20230263121A1
(en)
|
2020-03-31 |
2023-08-24 |
Elo Life Systems |
Modulation of endogenous mogroside pathway genes in watermelon and other cucurbits
|
|
US20230159945A1
(en)
|
2020-04-09 |
2023-05-25 |
R.J. Reynolds Tobacco Company |
Method
|
|
BR112022020859A2
(pt)
|
2020-04-14 |
2023-04-11 |
Academisch Ziekenhuis Leiden |
Métodos para indução de eventos de duplicação em tandem endógenos
|
|
NL2025344B1
(en)
|
2020-04-14 |
2021-10-26 |
Academisch Ziekenhuis Leiden |
Methods for induction of endogenous tandem duplication events
|
|
US20210332388A1
(en)
|
2020-04-24 |
2021-10-28 |
Inscripta, Inc. |
Compositions, methods, modules and instruments for automated nucleic acid-guided nuclease editing in mammalian cells
|
|
WO2021224633A1
(en)
|
2020-05-06 |
2021-11-11 |
Orchard Therapeutics (Europe) Limited |
Treatment for neurodegenerative diseases
|
|
CA3177093A1
(en)
|
2020-05-06 |
2021-11-11 |
Cellectis S.A. |
Methods for targeted insertion of exogenous sequences in cellular genomes
|
|
EP4146284A1
(en)
|
2020-05-06 |
2023-03-15 |
Cellectis S.A. |
Methods to genetically modify cells for delivery of therapeutic proteins
|
|
WO2021226558A1
(en)
|
2020-05-08 |
2021-11-11 |
The Broad Institute, Inc. |
Methods and compositions for simultaneous editing of both strands of a target double-stranded nucleotide sequence
|
|
US20230183664A1
(en)
|
2020-05-11 |
2023-06-15 |
Precision Biosciences, Inc. |
Self-limiting viral vectors encoding nucleases
|
|
US11787841B2
(en)
|
2020-05-19 |
2023-10-17 |
Inscripta, Inc. |
Rationally-designed mutations to the thrA gene for enhanced lysine production in E. coli
|
|
JP2023526670A
(ja)
|
2020-05-22 |
2023-06-22 |
インシトロ インコーポレイテッド |
機械学習モデルを使用した疾患の転帰の予測
|
|
JP2023527446A
(ja)
|
2020-05-29 |
2023-06-28 |
カー・ヴェー・エス ザート エス・エー ウント コー． カー・ゲー・アー・アー |
植物単数体の誘導
|
|
WO2021245435A1
(en)
|
2020-06-03 |
2021-12-09 |
Vilmorin & Cie |
Melon plants resistant to scab disease, aphids and powdery mildew
|
|
EP4161552A1
(en)
|
2020-06-05 |
2023-04-12 |
The Broad Institute, Inc. |
Compositions and methods for treating neoplasia
|
|
EP4161252A1
(en)
|
2020-06-05 |
2023-04-12 |
Vilmorin & Cie |
Resistance in plants of solanum lycopersicum to the tobrfv
|
|
CA3182852A1
(en)
|
2020-06-19 |
2021-12-23 |
Fate Therapeutics, Inc. |
Combining ipsc-derived effector cell types for immunotherapy use
|
|
US20230305023A1
(en)
|
2020-06-25 |
2023-09-28 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Methods of treatment and diagnostic of pathological conditions associated with intense stress
|
|
JP2023531537A
(ja)
|
2020-06-30 |
2023-07-24 |
メンドゥス・ベスローテン・フェンノートシャップ |
卵巣癌ワクチンでの白血病由来細胞の使用
|
|
WO2022013268A1
(en)
|
2020-07-14 |
2022-01-20 |
KWS SAAT SE & Co. KGaA |
Methods for identifying and selecting maize plants with resistance to northern corn leaf blight
|
|
AU2021204717A1
(en)
|
2020-07-15 |
2022-02-03 |
Seminis Vegetable Seeds, Inc. |
Green Bean Plants with Improved Disease Resistance
|
|
DK4182297T3
(da)
|
2020-07-16 |
2025-12-01 |
Acuitas Therapeutics Inc |
Kationiske lipider til brug i lipid-nanopartikler
|
|
BR112023001272A2
(pt)
|
2020-07-24 |
2023-04-04 |
Massachusetts Gen Hospital |
Partículas semelhantes a vírus aprimoradas e métodos de uso das mesmas para entrega às células
|
|
EP4188395A1
(en)
|
2020-07-30 |
2023-06-07 |
Institut Curie |
Immune cells defective for socs1
|
|
US20260028412A1
(en)
|
2020-08-10 |
2026-01-29 |
Precision Biosciences, Inc. |
Antibodies and fragments specific for b-cell maturation antigen and uses thereof
|
|
US12152251B2
(en)
|
2020-08-25 |
2024-11-26 |
Kite Pharma, Inc. |
T cells with improved functionality
|
|
KR20230079367A
(ko)
|
2020-08-31 |
2023-06-07 |
예일 유니버시티 |
핵산을 세포에 전달하기 위한 조성물 및 방법
|
|
JPWO2022050413A1
(enExample)
|
2020-09-04 |
2022-03-10 |
|
|
|
EP4210722A1
(en)
|
2020-09-07 |
2023-07-19 |
Institut National de la Santé et de la Recherche Médicale (INSERM) |
Methods of treatment of inflammatory bowel diseases
|
|
EP4214314A4
(en)
|
2020-09-15 |
2024-10-16 |
Inscripta, Inc. |
Crispr editing to embed nucleic acid landing pads into genomes of live cells
|
|
EP3971295A1
(en)
|
2020-09-16 |
2022-03-23 |
FRAUNHOFER-GESELLSCHAFT zur Förderung der angewandten Forschung e.V. |
Methods for the production of genome edited plants
|
|
JP2023542348A
(ja)
|
2020-09-23 |
2023-10-06 |
クリスパー セラピューティクス アクチェンゲゼルシャフト |
Ｒｅｇｎａｓｅ－１及び／又はＴＧＦＢＲＩＩを破壊した遺伝子操作されたＴ細胞は機能性及び持続性を改善させた
|
|
JP2023543803A
(ja)
|
2020-09-24 |
2023-10-18 |
ザ ブロード インスティテュート，インコーポレーテッド |
プライム編集ガイドｒｎａ、その組成物、及びその使用方法
|
|
JP7830442B2
(ja)
|
2020-10-02 |
2026-03-16 |
ビルモラン エ コンパニー |
貯蔵寿命が延長されたメロン
|
|
WO2022076547A1
(en)
|
2020-10-07 |
2022-04-14 |
Precision Biosciences, Inc. |
Lipid nanoparticle compositions
|
|
US20240060079A1
(en)
|
2020-10-23 |
2024-02-22 |
Elo Life Systems |
Methods for producing vanilla plants with improved flavor and agronomic production
|
|
US20230416709A1
(en)
|
2020-11-06 |
2023-12-28 |
Editforce, Inc. |
Foki nuclease domain mutant
|
|
EP4240874A1
(en)
|
2020-11-06 |
2023-09-13 |
Institut National de la Santé et de la Recherche Médicale (INSERM) |
Methods for diagnosis and treating polycystic ovary syndrome (pcos)
|
|
US11512297B2
(en)
|
2020-11-09 |
2022-11-29 |
Inscripta, Inc. |
Affinity tag for recombination protein recruitment
|
|
EP4244384A4
(en)
|
2020-11-10 |
2024-10-23 |
Mayo Foundation for Medical Education and Research |
METHODS AND MATERIALS FOR TREATING HEART FAILURE
|
|
EP4244347A1
(en)
|
2020-11-10 |
2023-09-20 |
Industrial Microbes, Inc. |
Microorganisms capable of producing poly(hiba) from feedstock
|
|
IL302983A
(en)
|
2020-11-20 |
2023-07-01 |
Revivicor Inc |
Multitransgenic pigs with growth hormone receptor silencing for xenotransplantation
|
|
US20220159905A1
(en)
|
2020-11-23 |
2022-05-26 |
Monsanto Technology Llc |
Management of corn through semi-dwarf systems
|
|
EP4251282A1
(en)
|
2020-11-27 |
2023-10-04 |
Institut National de la Santé et de la Recherche Médicale (INSERM) |
Methods for diagnosis and monitoring of toxic epidermal necrolysis
|
|
US20230416786A1
(en)
|
2020-11-30 |
2023-12-28 |
Cellectis Sa |
Use of aminoquinoline compounds for higher gene integration
|
|
WO2022117884A1
(en)
|
2020-12-03 |
2022-06-09 |
Vilmorin & Cie |
Tomato plants resistant to tobrfv, tmv, tomv and tommv and corresponding resistance genes
|
|
US11661459B2
(en)
|
2020-12-03 |
2023-05-30 |
Century Therapeutics, Inc. |
Artificial cell death polypeptide for chimeric antigen receptor and uses thereof
|
|
TW202237827A
(zh)
|
2020-12-03 |
2022-10-01 |
美商世紀治療股份有限公司 |
經基因工程改造之細胞及其用途
|
|
EP4019639A1
(en)
|
2020-12-22 |
2022-06-29 |
KWS SAAT SE & Co. KGaA |
Promoting regeneration and transformation in beta vulgaris
|
|
EP4019638A1
(en)
|
2020-12-22 |
2022-06-29 |
KWS SAAT SE & Co. KGaA |
Promoting regeneration and transformation in beta vulgaris
|
|
US20220193134A1
(en)
|
2020-12-23 |
2022-06-23 |
Crispr Therapeutics Ag |
Co-use of lenalidomide with car-t cells
|
|
JP2024501022A
(ja)
|
2020-12-28 |
2024-01-10 |
アークトゥルス セラピューティクス， インコーポレイテッド |
Ｈｂｖを標的とする転写活性化因子様エフェクターヌクレアーゼ（ｔａｌｅｎ）
|
|
WO2022146497A1
(en)
|
2021-01-04 |
2022-07-07 |
Inscripta, Inc. |
Mad nucleases
|
|
US20240376451A1
(en)
|
2021-01-07 |
2024-11-14 |
Inscripta, Inc. |
Mad nucleases
|
|
WO2022150790A2
(en)
|
2021-01-11 |
2022-07-14 |
The Broad Institute, Inc. |
Prime editor variants, constructs, and methods for enhancing prime editing efficiency and precision
|
|
KR20230142500A
(ko)
|
2021-01-12 |
2023-10-11 |
마치 테라퓨틱스, 인크. |
콘텍스트-의존적, 이중-가닥 dna-특이적 데아미나제및 이의 용도
|
|
CN116981697A
(zh)
|
2021-01-14 |
2023-10-31 |
森迪生物科学公司 |
可分泌有效载荷调节
|
|
EP4281102A1
(en)
|
2021-01-22 |
2023-11-29 |
Mendus B.V. |
Methods of tumor vaccination
|
|
WO2022165111A1
(en)
|
2021-01-28 |
2022-08-04 |
Precision Biosciences, Inc. |
Modulation of tgf beta signaling in genetically-modified eukaryotic cells
|
|
US11884924B2
(en)
|
2021-02-16 |
2024-01-30 |
Inscripta, Inc. |
Dual strand nucleic acid-guided nickase editing
|
|
US12553030B2
(en)
|
2021-03-09 |
2026-02-17 |
Crispr Therapeutics Ag |
Genetically engineered T cells with PTPN2 knockout have improved functionality and anti-tumor activity
|
|
CA3212351A1
(en)
|
2021-03-12 |
2022-09-15 |
Mendus B.V. |
Methods of vaccination and use of cd47 blockade
|
|
WO2022198093A1
(en)
|
2021-03-18 |
2022-09-22 |
Calyxt, Inc. |
Producing albumin using plant cell matrices
|
|
WO2022198106A1
(en)
|
2021-03-18 |
2022-09-22 |
Calyxt, Inc. |
Producing betalains using plant cell matrices
|
|
WO2022198094A1
(en)
|
2021-03-18 |
2022-09-22 |
Calyxt, Inc. |
Producing albumin in cannabaceae plant parts
|
|
WO2022198107A1
(en)
|
2021-03-18 |
2022-09-22 |
Calyxt, Inc. |
Producing betalain in cannabaceae plant parts
|
|
MX2023010985A
(es)
|
2021-03-18 |
2024-01-26 |
Calyxt Inc |
Matrices de celulas vegetales y procedimientos de las mismas.
|
|
WO2022208489A1
(en)
|
2021-04-02 |
2022-10-06 |
Vilmorin & Cie |
Semi-determinate or determinate growth habit trait in cucurbita
|
|
CA3214661A1
(en)
|
2021-04-07 |
2022-10-13 |
Century Therapeutics, Inc. |
Combined artificial cell death/reporter system polypeptide for chimeric antigen receptor cell and uses thereof
|
|
CA3214473A1
(en)
|
2021-04-07 |
2022-10-13 |
Century Therapeutics, Inc. |
Compositions and methods for generating alpha-beta t cells from induced pluripotent stem cells
|
|
IL307358A
(en)
|
2021-04-07 |
2023-11-01 |
Century Therapeutics Inc |
Compositions and methods for generating gamma-delta t cells from induced pluripotent stem cells
|
|
WO2022218998A1
(en)
|
2021-04-13 |
2022-10-20 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Methods for treating hepatitis b and d virus infection
|
|
US20240141311A1
(en)
|
2021-04-22 |
2024-05-02 |
North Carolina State University |
Compositions and methods for generating male sterile plants
|
|
AU2022261125A1
(en)
|
2021-04-23 |
2023-11-23 |
University Of Rochester |
Genome editing by directed non-homologous dna insertion using a retroviral integrase-cas fusion protein and methods of treatment
|
|
AU2022267804A1
(en)
|
2021-04-30 |
2023-12-14 |
Cellectis S.A. |
New anti-muc1 cars and gene edited immune cells for solid tumors cancer immunotherapy
|
|
EP4337769A1
(en)
|
2021-05-10 |
2024-03-20 |
SQZ Biotechnologies Company |
Methods for delivering genome editing molecules to the nucleus or cytosol of a cell and uses thereof
|
|
JP2024518094A
(ja)
|
2021-05-14 |
2024-04-24 |
ベクトン・ディキンソン・アンド・カンパニー |
多重非バイアス核酸増幅法
|
|
EP4341390A4
(en)
|
2021-05-14 |
2025-02-19 |
Becton, Dickinson and Company |
METHODS FOR MANUFACTURING NUCLEIC ACID SEQUENCING LIBRARIES
|
|
WO2022251644A1
(en)
|
2021-05-28 |
2022-12-01 |
Lyell Immunopharma, Inc. |
Nr4a3-deficient immune cells and uses thereof
|
|
WO2022256437A1
(en)
|
2021-06-02 |
2022-12-08 |
Lyell Immunopharma, Inc. |
Nr4a3-deficient immune cells and uses thereof
|
|
WO2022271548A2
(en)
|
2021-06-23 |
2022-12-29 |
Massachusetts Institute Of Technology |
Compositions, methods and systems for the delivery of gene editing material to cells
|
|
KR20240054969A
(ko)
|
2021-07-07 |
2024-04-26 |
시버스 유럽 비.브이. |
인테인에 융합된 전사 활성화인자-유사 이펙터
|
|
WO2023283359A2
(en)
|
2021-07-07 |
2023-01-12 |
Omega Therapeutics, Inc. |
Compositions and methods for modulating secreted frizzled receptor protein 1 (sfrp1) gene expression
|
|
CA3221517A1
(en)
|
2021-07-30 |
2023-02-02 |
Monika KLOIBER-MAITZ |
Plants with improved digestibility and marker haplotypes
|
|
IL310564A
(en)
|
2021-08-06 |
2024-03-01 |
Vilmorin & Cie |
Resistance to Leveillula Taurica in pepper plant
|
|
JP7125727B1
(ja)
|
2021-09-07 |
2022-08-25 |
国立大学法人千葉大学 |
核酸配列改変用組成物および核酸配列の標的部位を改変する方法
|
|
WO2023042079A1
(en)
|
2021-09-14 |
2023-03-23 |
Crispr Therapeutics Ag |
Genetically engineered immune cells having a disrupted cd83 gene
|
|
KR20240088901A
(ko)
|
2021-09-17 |
2024-06-20 |
시버스 유럽 비.브이. |
칸나바세아에 세포 형질전환
|
|
EP4404740A1
(en)
|
2021-09-20 |
2024-07-31 |
Revivicor Inc. |
Multitransgenic pigs comprising ten genetic modifications for xenotransplantation
|
|
CN118284701A
(zh)
|
2021-09-27 |
2024-07-02 |
孟山都技术公司 |
用于转化从单子叶植物种子切除的胚外植体的组合物和方法
|
|
GB202113933D0
(en)
|
2021-09-29 |
2021-11-10 |
Genome Res Ltd |
Methods for gene editing
|
|
WO2023064367A1
(en)
|
2021-10-12 |
2023-04-20 |
Selecta Biosciences, Inc. |
Methods and compositions for attenuating anti-viral transfer vector igm responses
|
|
WO2023064872A1
(en)
|
2021-10-14 |
2023-04-20 |
Precision Biosciences, Inc. |
Combinations of anti-bcma car t cells and gamma secretase inhibitors
|
|
KR20240082391A
(ko)
|
2021-10-14 |
2024-06-10 |
론자 세일즈 아게 |
세포외 소포 생산을 위한 변형된 생산자 세포
|
|
KR20240099259A
(ko)
|
2021-10-14 |
2024-06-28 |
아스널 바이오사이언시스, 인크. |
공동 발현된 shrna 및 논리 게이트 시스템을 갖는 면역 세포
|
|
US20240408235A1
(en)
|
2021-10-19 |
2024-12-12 |
Precision Biosciences, Inc. |
Gene editing methods for treating alpha-1 antitrypsin (aat) deficiency
|
|
WO2023069881A1
(en)
|
2021-10-20 |
2023-04-27 |
University Of Rochester |
Treatment with genetically modified cells, and genetically modified cells per se, with increased competitive advantage and/or decreased competitive disadvantage
|
|
WO2023070043A1
(en)
|
2021-10-20 |
2023-04-27 |
Yale University |
Compositions and methods for targeted editing and evolution of repetitive genetic elements
|
|
EP4419679A1
(en)
|
2021-10-20 |
2024-08-28 |
University of Rochester |
Methods and compositions for rejuvenating cns glial populations by suppression of transcription factors
|
|
IL311786A
(en)
|
2021-10-21 |
2024-05-01 |
Vertex Pharma |
hypoimmune cells
|
|
US12577624B2
(en)
|
2021-11-02 |
2026-03-17 |
Monsanto Technology Llc |
Transgenic corn event ZM_BCS216090 and methods for detection and uses thereof
|
|
WO2023081923A1
(en)
|
2021-11-08 |
2023-05-11 |
Frequency Therapeutics, Inc. |
Platelet-derived growth factor receptor (pdgfr) alpha inhibitors and uses thereof
|
|
EP4430206A1
(en)
|
2021-11-10 |
2024-09-18 |
Encodia, Inc. |
Methods for barcoding macromolecules in individual cells
|
|
US20250009800A1
(en)
|
2021-11-16 |
2025-01-09 |
Precision Biosciences, Inc. |
Methods for cancer immunotherapy
|
|
IL312721A
(en)
|
2021-11-23 |
2024-07-01 |
Cellectis Sa |
New tale protein scaffolds with improved on-target/off-target activity ratios
|
|
WO2023093862A1
(en)
|
2021-11-26 |
2023-06-01 |
Epigenic Therapeutics Inc. |
Method of modulating pcsk9 and uses thereof
|
|
GB202117314D0
(en)
|
2021-11-30 |
2022-01-12 |
Clarke David John |
Cyclic nucleic acid fragmentation
|
|
WO2023102393A1
(en)
|
2021-11-30 |
2023-06-08 |
Pioneer Hi-Bred International, Inc. |
High efficiency large scale chromosomal genome manipulation
|
|
US20250223584A2
(en)
|
2021-12-03 |
2025-07-10 |
The Broad Institute, Inc. |
Compositions and methods for efficient in vivo delivery
|
|
AU2022400961A1
(en)
|
2021-12-03 |
2024-05-30 |
President And Fellows Of Harvard College |
Self-assembling virus-like particles for delivery of nucleic acid programmable fusion proteins and methods of making and using same
|
|
US20230193310A1
(en)
|
2021-12-10 |
2023-06-22 |
Seminis Vegetabe Seeds, Inc. |
Lettuce plants having resistance to downy mildew
|
|
GB202118058D0
(en)
|
2021-12-14 |
2022-01-26 |
Univ Warwick |
Methods to increase yields in crops
|
|
WO2023109887A1
(zh)
|
2021-12-15 |
2023-06-22 |
南京金斯瑞生物科技有限公司 |
一种整合位点的检测方法
|
|
WO2023111913A1
(en)
|
2021-12-15 |
2023-06-22 |
Crispr Therapeutics Ag |
Engineered anti-liv1 cell with regnase-1 and/or tgfbrii disruption
|
|
WO2023114943A2
(en)
|
2021-12-16 |
2023-06-22 |
Acuitas Therapeutics, Inc. |
Lipids for use in lipid nanoparticle formulations
|
|
EP4449421A4
(en)
*
|
2021-12-17 |
2025-12-24 |
Altius Inst For Biomedical Sciences |
Nucleic acid sequences encoding recombination-resistant repeated sequences in viruses
|
|
WO2023119201A2
(en)
|
2021-12-22 |
2023-06-29 |
Crispr Therapeutics Ag |
Genetically engineered t cells with disrupted casitas b-lineage lymphoma proto-oncogene-b (cblb) and uses thereof
|
|
EP4456910A1
(en)
|
2021-12-28 |
2024-11-06 |
Mnemo Therapeutics |
Immune cells with inactivated suv39h1 and modified tcr
|
|
CA3241882A1
(en)
|
2021-12-29 |
2023-07-06 |
Bristol-Myers Squibb Company |
Generation of landing pad cell lines
|
|
WO2023129937A1
(en)
|
2021-12-29 |
2023-07-06 |
Century Therapeutics, Inc. |
Genetically engineered cells having anti-cd19 / anti-cd22 chimeric antigen receptors, and uses thereof
|
|
WO2023150557A1
(en)
|
2022-02-01 |
2023-08-10 |
University Of Rochester |
Methods of generating a population of neurons from human glial progenitor cells and genetic constructs for carrying out such methods
|
|
EP4472737A1
(en)
|
2022-02-01 |
2024-12-11 |
University of Rochester |
Gpr17 promoter-based targeting and transduction of glial progenitor cells
|
|
US20250215443A1
(en)
|
2022-02-03 |
2025-07-03 |
Nicoventures Trading Limited |
Method of modulating alkaloid content in tobacco plants
|
|
WO2023148476A1
(en)
|
2022-02-03 |
2023-08-10 |
Nicoventures Trading Limited |
Method of modulating alkaloid content in tobacco plants
|
|
EP4472405A1
(en)
|
2022-02-04 |
2024-12-11 |
Nicoventures Trading Limited |
Method of modulating alkaloid content in tobacco plants
|
|
EP4479080A1
(en)
|
2022-02-16 |
2024-12-25 |
Dana-Farber Cancer Institute, Inc. |
Methods for decreasing pathologic alpha-synuclein using agents that modulate fndc5 or biologically active fragments thereof
|
|
JP2025507751A
(ja)
|
2022-03-01 |
2025-03-21 |
クリスパー・セラピューティクス・アクチェンゲゼルシャフト |
アンジオポエチン様３（ａｎｇｐｔｌ３）関連状態を処置するための方法および組成物
|
|
WO2023172624A1
(en)
|
2022-03-09 |
2023-09-14 |
Selecta Biosciences, Inc. |
Immunosuppressants in combination with anti-igm agents and related dosing
|
|
WO2023180904A1
(en)
|
2022-03-21 |
2023-09-28 |
Crispr Therapeutics Ag |
Methods and compositions for treating lipoprotein-related diseases
|
|
WO2023180968A1
(en)
|
2022-03-23 |
2023-09-28 |
Crispr Therapeutics Ag |
Anti-cd19 car-t cells with multiple gene edits and therapeutic uses thereof
|
|
TW202346575A
(zh)
|
2022-03-23 |
2023-12-01 |
瑞士商Ｃｒｉｓｐｒ治療公司 |
具有ｒｅｇｎａｓｅ－１及／或ｔｇｆｂｒｉｉ破壞的抗ｃｄ８３ ｃａｒ－ｔ細胞
|
|
EP4256950A1
(en)
|
2022-04-06 |
2023-10-11 |
Vilmorin et Cie |
Tolerance to cgmmv in cucumber
|
|
GB202205149D0
(en)
|
2022-04-07 |
2022-05-25 |
Nicoventures Trading Ltd |
Method
|
|
GB202205148D0
(en)
|
2022-04-07 |
2022-05-25 |
Nicoventures Trading Ltd |
Method
|
|
AU2023248529A1
(en)
|
2022-04-08 |
2024-10-24 |
Fate Therapeutics, Inc. |
Chimeric antigen receptor for tumor targeting
|
|
CN119256075A
(zh)
|
2022-04-08 |
2025-01-03 |
菲特治疗公司 |
具有实体瘤靶向骨架的细胞及其用途
|
|
GB202205562D0
(en)
|
2022-04-14 |
2022-06-01 |
Nicoventures Trading Ltd |
Method
|
|
GB202205561D0
(en)
|
2022-04-14 |
2022-06-01 |
Nicoventures Trading Ltd |
Method
|
|
GB202206107D0
(en)
|
2022-04-27 |
2022-06-08 |
Nicoventures Trading Ltd |
Method
|
|
GB202206109D0
(en)
|
2022-04-27 |
2022-06-08 |
Nicoventures Trading Ltd |
Method
|
|
JP2025515030A
(ja)
|
2022-05-02 |
2025-05-13 |
フォンダジオン テレソン イーティーエス |
遺伝子編集用の相同性非依存性標的組込み
|
|
WO2023220603A1
(en)
|
2022-05-09 |
2023-11-16 |
Regeneron Pharmaceuticals, Inc. |
Vectors and methods for in vivo antibody production
|
|
EP4526459A2
(en)
|
2022-05-17 |
2025-03-26 |
Nvelop Therapeutics, Inc. |
Compositions and methods for efficient in vivo delivery
|
|
CN119947735A
(zh)
|
2022-05-19 |
2025-05-06 |
莱尔免疫制药公司 |
靶向nr4a3的多核苷酸及其用途
|
|
EP4278891A1
(en)
|
2022-05-20 |
2023-11-22 |
KWS SAAT SE & Co. KGaA |
Clubroot resistance and markers in brassica
|
|
EP4279085A1
(en)
|
2022-05-20 |
2023-11-22 |
Mnemo Therapeutics |
Compositions and methods for treating a refractory or relapsed cancer or a chronic infectious disease
|
|
GB202207774D0
(en)
|
2022-05-26 |
2022-07-13 |
Cambridge Entpr Ltd |
Modified plants
|
|
WO2023240212A2
(en)
|
2022-06-08 |
2023-12-14 |
Century Therapeutics, Inc. |
Genetically engineered cells having anti-cd133 / anti-egfr chimeric antigen receptors, and uses thereof
|
|
CN119698467A
(zh)
|
2022-06-08 |
2025-03-25 |
世纪治疗股份有限公司 |
衍生自遗传工程化以具有膜结合的il12的诱导多能干细胞的免疫效应细胞及其用途
|
|
AU2023284442A1
(en)
|
2022-06-08 |
2024-12-05 |
Century Therapeutics, Inc. |
Genetically engineered cells expressing cd16 variants and nkg2d and uses thereof
|
|
WO2023242827A2
(en)
|
2022-06-17 |
2023-12-21 |
Crispr Therapeutics Ag |
LIPID NANOPARTICLES (LNPs)-BASED OCULAR DELIVERY
|
|
WO2023248147A1
(en)
|
2022-06-21 |
2023-12-28 |
Crispr Therapeutics Ag |
Methods and compositions for in vivo editing of stem cells
|
|
WO2023250288A2
(en)
|
2022-06-21 |
2023-12-28 |
Seminis Vegetable Seeds, Inc. |
Novel qtls conferring resistance to cucumber mosaic virus
|
|
WO2023248145A1
(en)
|
2022-06-21 |
2023-12-28 |
Crispr Therapeutics Ag |
Compositions and methods for treating human immunodeficiency virus
|
|
CN119451992A
(zh)
|
2022-06-29 |
2025-02-14 |
克里斯珀医疗股份公司 |
靶向gpc-3的嵌合抗原受体和表达其的免疫细胞用于治疗用途
|
|
GB2621813A
(en)
|
2022-06-30 |
2024-02-28 |
Univ Newcastle |
Preventing disease recurrence in Mitochondrial replacement therapy
|
|
WO2024020360A1
(en)
|
2022-07-18 |
2024-01-25 |
Pairwise Plants Services, Inc. |
Mustard green plants named 'pwrg-1', 'pwrg-2,' and 'pwsgc'
|
|
KR20250042151A
(ko)
|
2022-07-22 |
2025-03-26 |
더 존스 홉킨스 유니버시티 |
덴드리머를 이용한 표적 세포 내 crispr/cas 시스템 전달 및 유전자 편집
|
|
WO2024023802A2
(en)
|
2022-07-29 |
2024-02-01 |
Crispr Therapeutics Ag |
Genetically engineered immune cells having disrupted transporter associated with antigen processing-2 (tap-2) gene
|
|
AU2023314808A1
(en)
|
2022-07-29 |
2025-03-20 |
Regeneron Pharmaceuticals, Inc. |
Compositions and methods for transferrin receptor (tfr)-mediated delivery to the brain and muscle
|
|
WO2024023804A2
(en)
|
2022-07-29 |
2024-02-01 |
Crispr Therapeutics Ag |
Genetically engineered immune cells having disrupted transporter associated with antigen processing binding protein (tapbp) gene
|
|
WO2024023801A2
(en)
|
2022-07-29 |
2024-02-01 |
Crispr Therapeutics Ag |
Genetically engineered immune cells having disrupted transporter associated with antigen processing-1 (tap-1) gene
|
|
LU502613B1
(en)
|
2022-08-01 |
2024-02-01 |
Plant Bioscience Ltd |
Methods of altering the starch granule profile in plants
|
|
CA3261296A1
(en)
|
2022-08-05 |
2024-02-08 |
Regeneron Pharmaceuticals, Inc. |
TDP-43 VARIANTS RESISTANT TO AGGREGATION
|
|
US20250386788A1
(en)
|
2022-08-26 |
2025-12-25 |
KWS SAAT SE & Co. KGaA |
Use of paired genes in hybrid breeding
|
|
WO2024062388A2
(en)
|
2022-09-20 |
2024-03-28 |
Crispr Therapeutics Ag |
Genetically engineered immune cells expressing chimeric antigen receptor targeting cd20
|
|
WO2024064952A1
(en)
|
2022-09-23 |
2024-03-28 |
Lyell Immunopharma, Inc. |
Methods for culturing nr4a-deficient cells overexpressing c-jun
|
|
WO2024064958A1
(en)
|
2022-09-23 |
2024-03-28 |
Lyell Immunopharma, Inc. |
Methods for culturing nr4a-deficient cells
|
|
WO2024062138A1
(en)
|
2022-09-23 |
2024-03-28 |
Mnemo Therapeutics |
Immune cells comprising a modified suv39h1 gene
|
|
GB202214410D0
(en)
|
2022-09-30 |
2022-11-16 |
Ivy Farm Tech Limited |
genetically modified cells
|
|
WO2024077174A1
(en)
|
2022-10-05 |
2024-04-11 |
Lyell Immunopharma, Inc. |
Methods for culturing nr4a-deficient cells
|
|
CA3265701A1
(en)
|
2022-10-11 |
2024-04-18 |
KWS SAAT SE & Co. KGaA |
VIRUS AND INSECT RESISTANCE AND MARKERS IN BARLEY
|
|
AU2023361162A1
(en)
|
2022-10-11 |
2025-05-29 |
Yale University |
Compositions and methods of using cell-penetrating antibodies
|
|
WO2024084025A1
(en)
|
2022-10-21 |
2024-04-25 |
Keygene N.V. |
Rna transfection in plant cells with modified rna
|
|
WO2024102838A1
(en)
|
2022-11-09 |
2024-05-16 |
Century Therapeutics, Inc. |
Engineered interleukin-7 receptors and uses thereof
|
|
IL320650A
(en)
|
2022-11-10 |
2025-07-01 |
Century Therapeutics Inc |
Genetically modified cells with chimeric anti-nectin 4 antigen receptors and uses thereof
|
|
WO2024107765A2
(en)
|
2022-11-14 |
2024-05-23 |
Regeneron Pharmaceuticals, Inc. |
Compositions and methods for fibroblast growth factor receptor 3-mediated delivery to astrocytes
|
|
EP4619515A1
(en)
|
2022-11-17 |
2025-09-24 |
The Broad Institute, Inc. |
Prime editor delivery by aav
|
|
JP2025540052A
(ja)
|
2022-12-01 |
2025-12-11 |
イェール ユニバーシティー |
細胞内ペイロード送達用刺激応答性トレースレス操作プラットフォーム
|
|
WO2024124044A1
(en)
|
2022-12-07 |
2024-06-13 |
The Brigham And Women’S Hospital, Inc. |
Compositions and methods targeting sat1 for enhancing anti¬ tumor immunity during tumor progression
|
|
WO2024121354A1
(en)
|
2022-12-08 |
2024-06-13 |
Keygene N.V. |
Duplex sequencing with covalently closed dna ends
|
|
WO2024138087A2
(en)
|
2022-12-23 |
2024-06-27 |
The Broad Institute, Inc. |
Methods and compositions for modulating cellular factors to increase prime editing efficiencies
|
|
EP4642225A1
(en)
|
2022-12-29 |
2025-11-05 |
Vilmorin & Cie |
Tomato plants resistant to resistance-breaking tswv strains and corresponding resistance genes
|
|
GB202219829D0
(en)
|
2022-12-29 |
2023-02-15 |
Ivy Farm Tech Limited |
Genetically manipulated cells
|
|
EP4652272A1
(en)
|
2023-01-18 |
2025-11-26 |
The Broad Institute Inc. |
Prime editing-mediated readthrough of premature termination codons (pert)
|
|
EP4652271A1
(en)
|
2023-01-18 |
2025-11-26 |
The Broad Institute, Inc. |
Base editing-mediated readthrough of premature termination codons (bert)
|
|
GB202300905D0
(en)
|
2023-01-20 |
2023-03-08 |
Nicoventures Trading Ltd |
Method
|
|
EP4658061A1
(en)
|
2023-02-01 |
2025-12-10 |
United Beet Seeds |
Beet yellows virus resistance
|
|
JP2026506602A
(ja)
|
2023-02-13 |
2026-02-25 |
アンスティチュ ナショナル ドゥ ラ サンテ エ ドゥ ラ ルシェルシュ メディカル |
鉄過剰関連疾患の処置方法
|
|
IL322416A
(en)
|
2023-02-15 |
2025-09-01 |
Arbor Biotechnologies Inc |
Gene editing method to inhibit abnormal splicing in stathmin 2 (stmn2) transcription
|
|
GB202303077D0
(en)
|
2023-03-02 |
2023-04-19 |
Univ Oslo |
Brassica plants with improved seed retention
|
|
WO2024192108A1
(en)
|
2023-03-14 |
2024-09-19 |
Evolveimmune Therapeutics, Inc. |
Genetically modified car t cells and methods of making and using the same
|
|
US12239091B2
(en)
|
2023-03-27 |
2025-03-04 |
Redsea Science And Technology Inc. |
Tomato plant designated ‘MX20-06’
|
|
AU2024246543A1
(en)
|
2023-03-31 |
2025-10-30 |
Briacell Therapeutics Corp. |
Methods for enhancing the immunogenicity of cellular vaccines
|
|
WO2024209000A1
(en)
|
2023-04-04 |
2024-10-10 |
Keygene N.V. |
Linkers for duplex sequencing
|
|
US20240344079A1
(en)
|
2023-04-14 |
2024-10-17 |
Seminis Vegetable Seeds, Inc. |
Methods and compositions for peronospora resistance in spinach
|
|
CN121311497A
(zh)
|
2023-04-14 |
2026-01-09 |
精密生物科学公司 |
肌肉特异性表达盒
|
|
WO2024216116A1
(en)
|
2023-04-14 |
2024-10-17 |
Precision Biosciences, Inc. |
Muscle-specific expression cassettes
|
|
IT202300007968A1
(it)
|
2023-04-21 |
2024-10-21 |
Fond Telethon Ets |
Metodi di editing genomico e costrutti
|
|
WO2024223402A1
(en)
|
2023-04-24 |
2024-10-31 |
Institut National de la Santé et de la Recherche Médicale |
Biallelic gene mutations for the diagnosis of neonatal systemic hypertension
|
|
WO2024226499A1
(en)
|
2023-04-24 |
2024-10-31 |
The Broad Institute, Inc. |
Compositions and methods for modifying fertility
|
|
EP4701406A1
(en)
|
2023-04-28 |
2026-03-04 |
Vilmorin & Cie |
Genetic determinants conferring improved tobrfv resistance
|
|
WO2024236547A1
(en)
|
2023-05-18 |
2024-11-21 |
Inceptor Bio, Llc |
Modified phagocytic cells expressing chimeric antigen receptors comprising a herpes virus entry mediator (hvem) co-stimulatory domain and uses thereof
|
|
WO2024243438A2
(en)
|
2023-05-23 |
2024-11-28 |
Omega Therapeutics, Inc. |
Compositions and methods for reducing cxcl9, cxcl10, and cxcl11 gene expression
|
|
WO2025003305A1
(en)
|
2023-06-28 |
2025-01-02 |
Vilmorin & Cie |
Pepper resistance to meloidogyne enterolobii
|
|
WO2025003461A1
(en)
|
2023-06-30 |
2025-01-02 |
Institut National de la Santé et de la Recherche Médicale |
Methods of treatment of metabolic disorders
|
|
WO2025022290A1
(en)
|
2023-07-21 |
2025-01-30 |
Crispr Therapeutics Ag |
Modulating expression of alas1 (5'-aminolevulinate synthase 1) gene
|
|
CN121548346A
(zh)
|
2023-07-24 |
2026-02-17 |
维尔莫林公司 |
甜瓜对cysdv的抗性
|
|
WO2025046513A1
(en)
|
2023-08-29 |
2025-03-06 |
Inceptor Bio, Llc |
Methods of manufacturing myeloid-derived cells from hematopoietic stem cells and compositions and uses thereof
|
|
WO2025052001A1
(en)
|
2023-09-07 |
2025-03-13 |
Mnemo Therapeutics |
Methods and compositions for improving immune response
|
|
EP4520334A1
(en)
|
2023-09-07 |
2025-03-12 |
Mnemo Therapeutics |
Methods and compositions for improving immune response
|
|
WO2025059215A1
(en)
|
2023-09-12 |
2025-03-20 |
Aadigen, Llc |
Methods and compositions for treating or preventing cancer
|
|
WO2025064408A1
(en)
|
2023-09-18 |
2025-03-27 |
The Broad Institute, Inc. |
Compositions and methods for treating cardiovascular disease
|
|
WO2025064678A2
(en)
|
2023-09-20 |
2025-03-27 |
The Broad Institute, Inc. |
Prime editing-mediated readthrough of frameshift mutations (perf)
|
|
GB202314578D0
(en)
|
2023-09-22 |
2023-11-08 |
Univ Manchester |
Methods of producing homoplasmic modified plants or parts thereof
|
|
WO2025101938A2
(en)
|
2023-11-10 |
2025-05-15 |
Century Therapeutics, Inc. |
Genetically engineered cells having multi-transmembrane domain chimeric antigen receptors utilizing g protein-coupled receptor scaffolds, and uses thereof
|
|
WO2025106626A1
(en)
|
2023-11-15 |
2025-05-22 |
Century Therapeutics, Inc. |
Genetically engineered cells expressing c-x-c chemokine receptor type 4, and uses thereof
|
|
WO2025128981A1
(en)
|
2023-12-14 |
2025-06-19 |
Sohm, Inc. |
Compositions and methods for genome editing
|
|
WO2025163107A1
(en)
|
2024-02-01 |
2025-08-07 |
Institut Gustave Roussy |
Immune cells defective for znf217 and uses thereof
|
|
WO2025186726A1
(en)
|
2024-03-05 |
2025-09-12 |
Crispr Therapeutics Ag |
Modulating expression of agt (angiotensinogen) gene
|
|
WO2025186284A1
(en)
|
2024-03-05 |
2025-09-12 |
Vilmorin & Cie |
Increased yield in cucumber
|
|
WO2025207795A1
(en)
|
2024-03-26 |
2025-10-02 |
Juno Therapeutics, Inc. |
Genetically engineered cells having anti-cd33 / anti-cd123 chimeric antigen receptors, and uses thereof
|
|
WO2025207798A1
(en)
|
2024-03-26 |
2025-10-02 |
Century Therapeutics, Inc. |
Genetically engineered cells having anti-cd123 chimeric antigen receptors, and uses thereof
|
|
WO2025215354A1
(en)
|
2024-04-08 |
2025-10-16 |
Ivy Farm Technologies Limited |
Method of culturing an animal cell
|
|
WO2025217398A1
(en)
|
2024-04-10 |
2025-10-16 |
Lyell Immunopharma, Inc. |
Methods for culturing cells with improved culture medium
|
|
WO2025217462A1
(en)
|
2024-04-10 |
2025-10-16 |
Garuda Therapeutics, Inc. |
Immune compatible cells for allogeneic cell therapies to cover global, ethnic, or disease- specific populations
|
|
WO2025224715A1
(en)
|
2024-04-26 |
2025-10-30 |
King Abdullah Univeristy Of Science And Technology |
Methods for improving precise genome modification and reducing unwanted mutations by crispr-cas editing
|
|
WO2025235388A1
(en)
|
2024-05-06 |
2025-11-13 |
Regeneron Pharmaceuticals, Inc. |
Transgene genomic identification by nuclease-mediated long read sequencing
|
|
WO2025247951A1
(en)
|
2024-05-28 |
2025-12-04 |
Institut Gustave Roussy |
Fyn kinase inhibitors, combinations and uses thereof
|
|
US20250382627A1
(en)
|
2024-06-13 |
2025-12-18 |
J.R. Simplot Company |
Engineering remontant flowering in rosaceae
|
|
WO2026006832A1
(en)
|
2024-06-28 |
2026-01-02 |
University Of Connecticut |
Gene modulation for treating cancer
|
|
WO2026017833A1
(en)
|
2024-07-17 |
2026-01-22 |
Vilmorin & Cie |
Tswv-resistant pepper
|
|
GB202411278D0
(en)
|
2024-07-31 |
2024-09-11 |
Uea Enterprises Ltd |
Methods of altering plant stress response
|
|
WO2026038057A1
(en)
|
2024-08-16 |
2026-02-19 |
Genome Research Limited |
Improved methods for gene editing
|
|
WO2026047626A1
(en)
|
2024-08-30 |
2026-03-05 |
Inceptor Bio, Llc |
Compositions and methods involving immune cells engineered for binding bispecific antibodies for use in cell therapy
|
|
WO2026046724A1
(en)
|
2024-08-30 |
2026-03-05 |
Cellectis Sa |
Tale protein scaffolds involving fusions of monopartite and bipartite nls
|